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Abstract 
Gold nanoparticles can self-assemble into nanostructures in the presence of suitable 
linker molecules. The self-assembly of gold nanoparticles functionalized with C-
reactive protein (CRP) antibodies in the presence of CRP antigen linker molecules was 
explored. A ratio of antigen linker molecules to nanoparticle (2:1) that resulted in rapid 
nanoparticle self-assembly was identified, evidenced as a distinct solution colour 
change from red to blue within 5 minutes. Higher linker molecule- nanoparticle ratios 
(12:1, 18:1, 72:1) resulted in slow formation of nanostructures and only a slight solution 
colour change (even after periods of several days), the rate being dependent on the 
number of available binding sites. The propensity of nanoparticles to rapidly assemble 
into nanostructures at certain linker molecule-nanoparticle ratios was corroborated 
employing citrate-stabilized nanoparticles and di-isothiocyanate terminated metal 
organic rhenium linker molecules whereby again rapid formation of nanostructures was 
dependent on a specific molecule-nanoparticle ratio as distinct from other molecule-
nanoparticle ratios. UV-visible spectroscopy and scanning electron microscopy 
characterization confirmed visual observations. Surface-based assays also show much 
promise in application to point-of-care detection. It was of interest to determine if 
surface-based assays void of complex chemical processes and elaborate equipment 
could compete with laboratory-based assays in terms of specificity, stability and 
sensitivity but also offer faster and inexpensive diagnosis. The binding of CRP antibody 
to silanised silicon-silicon oxide substrates implemented using the organosilane APTES 
and the subsequent binding of CRP antigen to this immobilised CRP antibody was 
explored. The binding event of CRP antigen to surface immobilised CRP antibody was 
electrically characterised in ambient conditions. The formation of the antibody-antigen 
complex resulted in a corresponding decrease of the sensor capacitance at a CRP 
antigen concentration of 20 µg/mL (2 hours). However, it was demonstrated that 
nanoparticle amplification can facilitate rapid visual surface-based detection of CRP 
antigen of between 5 µg/mL and 20 µg/mL.  
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1.1 Historical perspective 
Gold, element 79 in the periodic table, has been prized for millennia. Gold is a noble 
metal among rhenium, ruthenium, rhodium, palladium, silver, osmium, iridium and 
platinum. The electron configuration of these elements imparts a certain chemical 
resistance to corrosion and oxidation. Since its extraction in the 5th millennium BC in 
Bulgaria1   gold has been used in a diverse range of applications from gold bands in 
dentures, as used by the Etruscans, to electronic circuit components some centuries 
later. Colloidal gold appeared ~500 BC in Egypt and China1 and was used throughout 
the middle ages for its perceived medicinal and curation powers. “Aurum potabile” or 
“potable gold”  was used for treatment of dysentery, tumours and diagnosis of syphilis.2 
The intense colours of gold sols resulted also in their use in art and ceramics for more 
than 2000 years. An excellent illustration of this is the Lycurgus Cup found in the 
British museum, in London, crafted by Romans in the 4thC AD.3 The cup changes 
colour depending on the lighting conditions. In reflected light it appears green - in 
transmission a bright red colour can be seen. The work of Barber deduced that the 
presence of a mix of gold and silver alloy particles of approximately 70 nm in size in 
the glass matrix of the vase was crucial to obtain the scarlet red colour.4,5 
The contemporary view of colloidal gold nanoparticles can be attributed to Michael 
Faraday. In 1857 Faraday reported formation of deep red solutions upon reduction of 
chloroaurate (AuCl4) aqueous solution with white phosphorous in a 2-phase CS2- water 
mixture (phosphorous dissolved in carbon disulphide).6 He reported that colloidal 
solutions he had synthesised exhibited colours ranging from ruby red to amethyst. He 
listed the factors impacting the colour of these solutions and deduced that “the mere 
variation in the size of particles gave rise to a variety of resultant colours.7 Faraday 
observed the crucial size and shape dependence on the resulting solution colours and 
properties of nanostructures. Much research has been conducted since Faraday’s initial 
observations with regard to optimising synthesis routes to develop nanoparticles with 
tunable plasmonic properties. Major advances in understanding the role of the various 
reaction parameters have allowed tight control over size and shape monodispersity, 
which has been essential in understanding the correlation between nanoparticle 
morphology and optical response.  
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In 1908, Mie presented a solution to Maxwell’s equations which facilitated the 
calculation of the extinction and scattering efficiencies of small metal particles.8,9 Later 
Stratton introduced a more formal approach, which is commonly used today.10 Mie’s 
application of Maxwell’s equations to explain the strong absorption of green light by a 
subwavelength gold sphere under plane-wave illumination established the foundation of 
an understanding of this phenomenon. In 1951 Turkevich11,12 developed one of the most 
popular approaches for the synthesis of gold nanoparticles using citrate reduction of 
HAuCl4 in H2O. Great advancement has been made with regard to fabrication methods 
also, which provide us with good control over the composition and morphology of 
nanostructured metals. A wide variety of lithographic13,14,15 and other physical methods 
have been devised and sophisticated characterisation techniques and modelling methods 
have also dramatically enhanced the field. 
Faraday’s experiments with colloidal gold were the beginning of today’s 
nanotechnological revolution. Faraday went on to publish an excellent paper on small 
particle optics that constituted a Bakerian lecture in 1857.7 A sol prepared by Faraday is 
still displayed in the Royal Institution of Great Britain.2 Its violet colour is immediate 
visual proof of the reluctance of the gold colloidal particles to aggregate into a more 
massive gold sample despite the strong thermodynamic impulse to do so. Establishing 
an understanding of these phenomena has led to the evolution of gold from use in 
beautiful art as depicted in the Lycurgus Cup to the use of DNA to bind gold 
nanoparticles in 1996,16 to the approval of Verigene17 by the FDA in 201218, a gold 
nanoparticle diagnostic device to identify infectious bacteria. The sprinkling of gold 
once used to beautify art pieces now appears possible to vastly improve efficiency of 
solar cells to enabling more sensitive bio-detection. 
1.2 Birth of nanotechnology 
Since this technological milestone in 1857 an estimated 12.4 billion dollars19 has been 
invested in research in the area, development of multiple research groups, publication of 
thousands of journal articles and has resulted in the birth of some of the huge research 
fields, namely nanotechnology, nanoelectronics, nanoplasmonics and bio-
nanotechnology. The terms “nanomaterials” and “nanotechnology” have also been 
defined by the American Society for testing and materials and International 
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Organisation for Standardisation. Nanotechnology is described as technology based on 
materials with an upper size limit of ~100 nm in at least one of the dimensions2 - 
nanoparticles being a number of atoms or molecules bonded together (these particles 
usually containing 106 atoms or fewer). Nanostructures are intermediate in size between 
individual atoms and aggregates large enough to be termed bulk material.  
The properties of colloidal metals are strikingly different to those of their bulk 
counterparts due to the high surface to volume ratio,20 quantum size effects21 (in sub 1 
nm NPs) and electrodynamic interactions.22 Such unique metal nanoparticle optical, 
electrical, magnetic and mechanical properties make them a very attractive choice for, 
in particular, chemical and biological sensors23 and also other novel applications.   Bulk 
gold’s familiar yellow colour is caused by a reduction in reflectance of light at the end 
of the spectrum.24 When gold is subdivided into tiny particles, the ratio of the diameter 
to the wavelength becomes important and when particles of gold are small enough, the 
colour of gold is ruby red due to their strong absorbance of green light at ~520 nm 
corresponding to the frequency at which a plasmon resonance occurs with the gold.2 
Characteristically noble metals exhibit a strong absorbance band in the visible region of 
the spectrum25,26 which is indeed a small particle effect and is as a result of this surface 
plasmon resonance (SPR). All conduction metals support plasmons but the plasmon 
resonances of coinage metals (Cu, Ag, Au) lie closer to the visible region of the 
spectrum allowing plasmon excitation by standard optical sources and methods.27  
Plasmons are the collective oscillation of the electron gas in a metal.14 Optical waves 
can couple to these electron oscillations in the form of propagating surface waves or 
localised excitations, depending on the geometry. Small noble metal particles with 
dimensions from a few up to several 100 nanometers support localised surface plasmon 
oscillations that create large electromagnetic fields at the nanoparticle surface. The 
electric field of an incoming light wave induces a polarisation of the (free) conduction 
electrons with respect to the much heavier ionic core of a spherical nanoparticle.28 The 
positive charges in the particle are assumed to be immobile and the negative charges, 
that is, the conduction electrons,29 move under the influence of external fields. 
Therefore, a displacement of the negative charges from the positive ones occurs when 
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the metallic nanoparticle is placed in an electric field, i.e. there results a net charge 
difference at the nanoparticle boundaries.  
As a consequence, a dipolar oscillation of the electrons is created (with a particular time 
period), and this is known as the surface plasmon oscillation. The collective oscillation 
of the electrons is also sometimes denoted as the “dipole particle plasmon resonance” to 
differ from plasmon excitations that occur in bulk metal surfaces.27 The surface plasmon 
resonance is the coherent excitation of all the “free” electrons within the conduction 
band, leading to an in-plane oscillation.14 The term “surface” stems from the fact that 
although all electrons are oscillating with respect to positive-ion background, the main 
effect producing the restoring force is the surface polarization.2 Plasmons also exist in 
the bulk and at the surface of large chunks of material. However, because of a mismatch 
between the plasmon dispersion relation and that of the photon, the plasmons cannot be 
excited by ordinary plane-polarised light. Oscillating frequency is critically determined 
by 4 factors: the density of the electrons, the effective electron mass, the shape and the 
size of the charge distribution.30 Therefore, the dielectric constant of the surrounding 
medium, the electronic interactions between the stabilising ligands and the nanoparticle 
and the size, shape and monodispersity of the nanoparticles all have a strong impact on 
the position, size and shape of the surface plasmon band.31  
With control over the composition and morphology of nanostructured metals, the next 
goal was to bridge the basic (wet chemical) fabrication of these nanoplasmonic building 
blocks and bring all of the advancements to the stage where these developments can 
bridge the gap between nanomaterials and successful technological applications. Among 
the possible applications of the above mentioned surface plasmon band property of 
colloidal gold, detection is the one that has been most successful thus far. The ability of 
surface plasmon band to be altered in an easy, controlled and reproducible way by a 
change in the environment or nanoparticle properties, in particular localised surface 
plasmon bands in metal nanoparticles displaying extreme sensitivity to environmental 
changes,32 therefore being excellent transducers for sensing devices, naturally led 
researchers to use them as sensors to detect organic, inorganic and biological 
targets.33,34,35 The extremely high extinction co-efficients36 and the strong distance 
dependent optical properties of gold nanoparticles enable the nanoparticles to be ideal 
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colour reporting groups - extinction co-efficients are 3-5 orders of magnitude greater 
than that of organic compounds. This has been applied in biosensing because the local 
refractive index may change significantly when a target analyte binds to a biomolecule 
receptor that has been previously bound to the nanoparticles. The property of 
nanoparticles to feature a changing SPB in solution depending on the mean distance 
between them has therefore been extensively exploited in the field of biodetection and 
sensing having been used for biosensing since 1956.37 
1.3 Bridging between nanomaterials and technological applications 
The assembly and integration of nanoscale objects is of pivotal significance for the 
design and fabrication of nanodevices. Chemists have already made important progress 
in relation to precisely controlling size and shape of nanoscale objects as well as their 
surface chemistries34. There are hundreds if not thousands of procedures available that 
allow for crafting the sizes, shapes, material properties or surface chemistries of 
nanoscopic particles19  using a multitude of syntheses. Various methods have been 
employed in the assembly of gold nanoparticles, using DNA,38 polymer39,40  and organic 
ligands.41 Nanoscale objects can be easily assembled into aggregated nanostructures 
through self-assembly. Self-assembly refers to the process by which nanoparticles or 
other discrete components spontaneously organise due to direct specific interactions 
and/or indirectly through their environment.42 Self-assembly is typically associated with 
thermodynamic equilibrium, the organised structures being characterised by a minimum 
in the systems Gibbs energy. Self-assembly is generally simple and low cost,43,44  being 
governed by the balance of attractive forces (covalent or hydrogen bonded, electrostatic 
attraction between oppositely charged ligands, depletion forces or dipole-dipole 
interactions) and repulsive forces (steric forces and electrostatic repulsion between 
ligands of like charge).42 
Solution-phase nanoparticle-based sensing through self-assembly is a simple yet 
powerful detection modularity. Because many molecules of interest, particularly 
biological molecules, are in the aqueous phase, it is desirable to have a sensitive and 
specific detection system that is homogeneous with the phase of the target molecule 
therefore decreasing the need for extended sample preparation. Aggregation-based 
detection has become a mainstay in the clinical community since the development of the 
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latex agglutination test (LAT) in 1956.37 The assembly of gold nanoparticles and the 
accompanying colour change have been the subject of intense research particularly in 
the past decade with numerous molecular or bio-molecular optical sensing platforms 
being developed based on the nanoparticle assembly principle.45,46,47,48 The colour 
changes observed upon assembly of the plasmonic nanoparticles originate from the 
coupling between the localised surface plasmons of the nanoparticles that result in lower 
energy excitation and red-shifted absorbance bands. 
Organisation of nanoparticles into self-assembled structures paves the way for reducing 
the size of optoelectronic devices and components such as plasmon waveguides, 
focusing lenses, light generation and optical switches, chemical and biological sensors, 
adaptive materials, photonics, electronics and photovoltaics.49 At present, many 
nanoparticle based opto-electronic components are made with top-down nanofabrication 
techniques, rather than bottom up self-assembled approaches. One key limitation of 
these fabrication methods is that it is difficult to obtain small separations (<10 nm) and 
curvatures.13 E-beam lithography, although having nanometre resolution, is limited to 
thin films, has low throughput and is prohibitively  expensive,50 whereas plasmonic 
characteristics of gold nanoparticles can be tuned spectrally down to the sub 50 nm 
resolution beyond the possibilities of lithographically structured films.15 
However, a major challenge for nanoparticle assembly is the lack of metrology to 
characterise the kinetics and structures in situ during the assembly process. In the last 20 
years a large number of experimental and theoretical studies have been carried out 
aimed at understanding the physical properties of the aggregation phenomena and key 
factors in driving nanoparticle assembly formation. It is of importance to characterise 
the process of self-assembly in a much more rigorous manner than at present, by 
moving the “proof of concept” experiments to the quantitative assessment of the self-
assembled structures. There are a number of questions regarding the molecular 
mechanism. Lack of such fundamental information mainly explains the current 
limitations facing linker-mediated self-assembly of inorganic nanoparticles.  
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1.4 Solution-phase detection of biomolecules 
Nanoparticles are stabilised as a result of capping ligands on the surface. If prepared 
with HAuCl4 as gold source and stabilised using trisodium-citrate, it leads to the 
coverage of citrate anions on the surface. The dissolved ions in the solvent readily cover 
the surface of the nanoparticles forming a film called the double layer enabling them to 
remain as a sol and not precipitate out of solution, due to the presence of this charged 
double layer surrounding each colloidal nanoparticle that produces a Coulomb barrier to 
aggregation. Helmholtz, Gouy and Chapman and then Stern studied the structure of the 
double layer. Depending on the surface potential of the nanoparticles and the cation 
affinity for the surface material, the ions may bond or adsorb on the nanoparticle surface 
creating an inner and outer Helmholtz plane. The Stern layer is delimited by a virtual 
plane (Stern plane) touching the ions aggregated on the surface. Ions in the Stern layer 
interact with counter ions of the solvent (by the means of the electrostatic force) by 
attracting them to accommodate the local surface charge thus creating a second layer. 
However in this case, the distribution of counter ions through space is diffuse and 
increases gradually to reach the bulk concentration. Conversely, ions presenting the 
same charge as the ones in the Stern layer also loosely occupy the second layer so that 
their local concentration decays to reach the bulk value. 
 
 
Figure 1.1: Schematic detailing the structure of the double-layer at an electrode surface, surface potential, 
𝜓𝜓𝑠𝑠; potential at the Stern layer, 𝜓𝜓𝑑𝑑; potential at the slipping plane, 𝜁𝜁. 
51 
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The resulting repulsive double layer interaction between the particles makes the sol very 
stable against aggregation. However, it is desirable to cause aggregation of these 
nanoparticles for the formation of assemblies with desirable novel properties. There are 
various different types of attractive and repulsive forces and whether or not the particles 
aggregate depends on the equilibrium between these attractive (covalent or hydrogen 
bonding, electrostatic attraction between oppositely charged ligands, depleting forces or 
dipole-diploe interactions) and repulsive forces (static forces and electrostatic repulsion 
between ligands of like charge).  
Aggregation processes for colloidal particles result from the coupling between two main 
interactions: particle fluid interactions which play a role in the motion of particles 
within a flow and govern the number of particle-particle encounters, as well as their 
time and spatial locations and secondly the collision step52 described by Derjaguin-
Laudau-Verwey-Overbeck (DLVO) theory. This theory is based on the principle that 
pairwise interaction forces, which arise from the interplay of attractive van der Waals 
forces and repulsive Coulomb forces, screened by Debye-Huckel ion clouds, dominate. 
Van der Waals forces originate from the electromagnetic fluctuations due to the 
incessant movements of positive and negative charges within all types of atoms, 
molecules and bulk materials. They are therefore present between any two material 
bodies, usually acting in an attractive fashion to bring the bodies together.19 This theory 
demonstrates that two surfaces (typically nanoparticle surfaces) can come into strong 
adhesive contact when the potential or charge they carry is lowered by a more effective 
ion binding (in the Stern layer) or by improving the double-layer screening by the 
means of an increase of the electrolyte salt concentration. However, if the surface 
potential or charge is not substantially decreased, the two surfaces may still adhere in a 
less stable and reversible configuration. The Derjaguin-Laudau-Verwey-Overbeck 
theory has been widely employed in colloid science to study particle-particle 
interactions, colloidal stability, coagulation, sedimentation, filtration, and the behaviour 
of electrolyte solutions.2   
Adsorption of ions and molecules on the surfaces of solid particles is a critical step in 
nanoparticle assembly. The thermodynamic driving force for adsorption at a surface is 
typically described using the concept of Gibbs energy. The overall Gibbs energy change 
for adsorption from solution onto a surface is a function of the chemical composition 
____________________________________________________________________Chapter 1 
 
10 
 
and structure of the solid, as well as the nature of the solution. For a fixed set of solution 
parameters, however, the influence of particle size on the adsorption can be described 
thermodynamically by an adsorption coefficient, which can be determined 
experimentally by measuring the extent of surface adsorption as a function of solution 
concentration. The relationship among this adsorption coefficient, Gibbs energy, and 
crystal size can be defined using a classical thermodynamic approach. To describe the 
influence of particle size on adsorption at particle surfaces, a simple Langmuir-type 
adsorption isotherm can be employed. In the Langmuir isotherm, the probability of a 
molecule adsorbing at any surface location is independent of the total surface coverage 
and dependent only on whether the specific adsorption site is already occupied. Since at 
equilibrium the surface coverage by adsorbate is dependent on the concentration of 
adsorbate molecules in solution through the isotherm, the charge on the nanoparticle’s 
surface will be a function of the concentration of adsorbate in solution.  
Aggregation occurs through two mechanisms. Aggregates can be formed primarily 
through the addition of single nanoparticles to a growing cluster, that is, cluster-particle 
aggregation, and second, clusters of all sizes can assimilate into larger clusters, that is, 
cluster-cluster aggregation. An aggregating colloid can switch from one mechanism to 
the other depending on the number of depleted nanoparticles in the solution. However, 
all nanoparticle aggregation processes begin with the formation of a nanoparticle dimer 
from two isolated nanoparticles. Particles may adhere together if their activation energy 
is larger than the energy barrier encountered.  
Monte Carlo simulations, Brownian dynamic simulations and the kinetic approach 
based on the population balance equations have been applied to describe these 
aggregation processes and have been the subject of numerous experimental, theoretical 
and computational studies.53,54,55,56 However, the mechanisms by which single 
nanoparticles assemble to form extended and branched chains is still not well 
understood and then poorly controlled which is a major limitation for their effective 
application. A better understanding of the mechanism and dynamics of the growth 
reaction during self-assembly relies on the precise control of the assembly over time and 
the ability to image the assembly at different stages of the process.  
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UV-visible spectroscopy provides characterisation of the transverse and longitudinal 
plasmon absorption bands of metallic nanoparticle aggregates.35 Highly dispersed gold 
nanoparticles (Au NPs) (effectively considered as single particles) in solution should 
exhibit only a single peak, while linked Au NP pairs or larger aggregates show two 
absorbance maxima.48 The first peak located near the resonance peak for single particles 
is attributed to the transverse plasmon excitation in coupled spheres, while the second 
peak at a higher wavelength is attributed to the longitudinal plasmon resonance of the 
Au NP aggregates. When gold NPs assemble, the resonance at wavelengths close to 530 
nm generally decreases in intensity and undergoes a slight red shift. In addition, the 
peak at higher wavelengths appears as a red-shifted shoulder. This is due to the decrease 
in the number of single NPs and the formation of dimers and oligomers. The frequency 
and intensity of the aggregated system depends on the degree of aggregation as well as 
orientation of the individual particles within the aggregate. Also an increase in the full 
width at half max (FWHM) of the new peaks is evident. This is mainly explained by the 
increase in the number density of the chains leading to a branched network. Importantly, 
the increase in the assembly degree is also signified by an increase in the solution 
transparency.57  
1.5 Employing biofunctionalised nanomaterials in biosensing 
Although localised surface plasmon resonance spectroscopy is a totally non-selective 
sensor platform, a high degree of analyte selectivity can be conferred using the 
specificity of surface attached ligands and passivation of the sensor surface to non-
specific binding. The nanoparticles in solution are rarely ‘‘naked’’. Their surface is 
usually covered with stabilising molecules, which, due to their affinity for the gold 
surface prevent the agglomeration and the further growth of the nanoparticles. Self-
assembled monolayers (SAMs) are easily grafted to a nanoparticle surface. The 
properties of the gold nanoparticles are then in large part determined by the monolayer 
which can bind specifically with particular biological materials including proteins, 
peptides, nucleic acids, DNA, RNA, genes, oligomers, aptamers, ribosomes, lipids, fatty 
acids or carbohydrates.58 The biologicals may be functionally active, offering binding, 
catalytic or therapeutic activity (eg. antibody or enzymes) or alternatively may be 
passively utilised as an inert coating or scaffolding material.  
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Gold nanoparticles unique optical and electrical properties offer applicability to a wide 
range of applications. Gold is one of the few metals noble enough to survive as a 
nanoparticle under atmospheric conditions. It is chemically inert, robust, has low 
toxicity, possible shape modulation, facile preparation and modification and excellent 
binding specificity of gold nanoparticles that offer a suitable platform for 
functionalisation with a wide variety of organic or biological ligands for the selective 
binding and detection of small molecules and biological targets.59,60,12 The integration of 
biomolecules with gold nanoparticles can generate materials that combine the properties 
of the nanoparticles with the molecular recognition components of biomolecules.  
Functionalisation is possible using ligands terminated in functionalities imparting 
desired surface properties. It is desired to have control of volume or ratio of 
biomolecules per nanoparticle and also having their binding sites in access to the 
environment while at the same time avoiding over-conjugation as non-specific chemical 
or electromagnetic interaction can result in heterogeneous attachment and impair 
activity in the final conjugate. It is necessary to maintain the optical function and 
activity of both participants and control over inter-particle distance. Capping molecules 
are employed to achieve this as they act not only to maintain a good dispersion of 
particles but also to selectively respond toward external stimuli. Therefore the 
distribution of capping molecules is highly relevant. 
1.6 Protein-functionalised nanomaterials 
Proteins have a vast array of potential sizes and surface chemistries that can be used to 
control the structure and functionality of nanoparticle-based materials providing 
versatile building blocks for nanoparticle assembly. Molecular interaction can be 
tailored and used to create ordered assemblies designing particles with stimuli 
responsive inter-particle interactions and morphological or functional features that result 
in directional interactions. Antibodies are serum proteins. They belong to the family of 
glycoproteins known as immunoglobulins. They are produced by white blood cells, the 
B lymphocytes on differentiation into plasma cells, in response to a foreign (non-self) 
substance. The foreign substance is termed an immunogen so defined because it evokes 
an immune response. Secreted antibodies circulate in the blood and serve as the 
effectors of humoral immunity by searching out and neutralising or eliminating foreign 
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substances such as viruses or bacterial toxins. In most instances an individual antibody 
is highly specific and will recognise one substance only61, this substance is termed the 
antigen. In assays and sensors based on antibodies, the analyte is either the 
corresponding antigen for the antibody used or a part of it.  
Antibodies are heterogeneous with respect to physiochemical properties and function 
but have similar basic structures. They consist of two kinds of polypeptide chains: 
heavy chains (50-70 kDa) and light chains (~25 kDa). Identical light-chain-heavy chain 
pairs are linked by disulphide bridges and non-covalent interactions. This results in a Y-
shaped structure. The light and heavy chains are made up of a number of segments or 
domains, each of approximately 110 amino acids. The light chains contain two domains, 
whereas the heavy chains have 3-5. It is the amino-terminated domains of both the light 
and heavy chains that are responsible for recognition and binding of antigen.62  
Antibody preparations may be polyclonal, affinity-purified monospecies or 
monoclonal.63 A polyclonal antiserum will contain many different antibody molecules 
with varying affinities and specificities. Monoclonal antibodies in contrast are produced 
in vitro by a single clone of antibody-producing cells and therefore all molecules from 
the clone have the same specificity and affinity. The choice of which antibody 
preparation to use depends on the antigen, the application of the assay and the time and 
money available. For monoclonal antibodies the purity of the antigen is not as important 
due to the cloning and selection procedures used during their production. Monoclonal 
antibodies offer the advantage that once a suitable and stable clone has been found, 
virtually unlimited quantities of a particular antibody can be produced. However, the 
production of a monoclonal antibody with the correct characteristics for any given assay 
is expensive and time consuming. Polyclonal antibody production however, is much 
cheaper and quicker.  In general the use of monoclonal antibodies increases the reaction 
specificity but potentially at the expense of the reaction sensitivity.  
The functional properties of the protein depend on the physiochemical characteristics of 
the system in which they are contained.62 The elemental properties of the protein are the 
amino acid composition, structure, conformational stability, charge, shape, size, the 
extent of polarity and hydrophobicity and the nature of protein-protein interactions. The 
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most important characteristics of the medium influencing the functioning properties of 
proteins are the solvent nature, pH, ionic strength, temperature, redox state and the 
presence of interfaces.64 An antibody will combine specifically with the corresponding 
antigen. Even a small change, for example, the substitution of one amino acid for 
another, moving a chemical group from one carbon to another, or using the mirror 
image of a chemical group may change the antibody-antigen fit from very good to weak 
or non-interacting. This qualifies them as very good biomaterials for use in sensing 
devices. The intermolecular forces which contribute to the stabilisation of the antibody-
antigen complex are the same as those involved in the stabilisation of the configuration 
of proteins or other macromolecules. These include hydrogen bonds, ionic bonds, 
hydrophobic interactions and van der Waals forces. Since the strength of each of these 
interactions is weak compared to that of a covalent bond, a large number of such 
interactions are required to form a strong antibody-antigen bond. As each of these non-
covalent interactions operates over a small distance, generally less than 1 angstrom, a 
strong antibody-antigen interaction therefore depends on a very close fit between the 
antibody and the antigen. Antigens contain numerous epitopes, which are the part of an 
antigen molecule to which an antibody attaches itself, but binding to a unique epitope is 
a highly specific interaction, providing the capacity for antibody-antigen recognition in 
solutions containing many different biomolecules. Once bound they are unlikely to 
desorb as attachment to the surface at one point on the protein increases the probability 
of binding a neighbouring site on the protein. However desorption requires the 
concurrent breaking of a large number of bonds, which is energetically unfavourable.  
1.7 C-reactive protein  
In 1930 Tillet and Francis observed a substance in the serum of individuals with 
pneumococcus infections that formed a precipitate when mixed with the polysaccharide 
coat of streptococcus pneumonia.65 They noticed that this activity was absent from the 
sera of healthy individuals. MacLeod and Avery subsequently characterised this 
substance as a protein and introduced the term “acute phase” to describe the serum of 
patients with various acute infections.66 C-reactive protein (CRP) is a non-specific 
protein secreted by the human body during the acute phase of the inflammation process 
and has historically been used to detect and predict the outcome of various infections, 
inflammatory and necrotic processes and to assess the efficacy of treatment for those 
processes.67,68 
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This protein has been highly conserved during evolution. It belongs to a family of 
pentameric proteins known as pentraxins. It has the same functional and structural 
homology as a protein that is detected in high concentrations in the hemolymph of the 
horseshoe crab (Limulus polyphemus), a “living fossil.69 CRP comprises five identical, 
non-covalently bound subunits arranged in cyclic symmetry and each subunit consists 
of 206 amino acid residues.70 The outer diameter is ~ 11.13 nm, the inner diameter ~ 
3.52 nm and the height ~ 3.03 nm. CRP exists in at least two distinct forms in 
conformation, i.e. pentamer (or native) CRP (pCRP) and modified CRP (mCRP). The 
molecular weight of pCRP is 115 kDa. The mCRP is the subunit of pCRP and its 
molecular weight is 23 kDa.70 The structure of CRP contains an area where the calcium-
binding loop from one protomer coordinates into the calcium site of a second protomer 
to form the pentameric structure. This configuration allows for the binding of the ligand 
phosphocholine and provides information concerning conformational changes related to 
calcium binding.  
 
 
Figure 1.2: Computer-generated image of the structure of C-Reactive Protein. 71 
 
CRP is one of the most consistently increased and fastest reacting acute-phase proteins 
(biological half-life of 19 hours), suggesting that it is part of the innate immune 
response. Concentrations may increase 1000-fold or more within 24–48 hours of tissue 
injury. Serum concentrations rise above 5 μg/mL after about 6 hours and peak at around 
48 hours. The plasma half-life of CRP is constant under all conditions of health and 
disease so that the sole determinant of circulating CRP concentrations is the synthesis 
rate which thus directly reflects the intensity of the pathological processes stimulating 
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CRP production. When the stimulus for increased production completely ceases, the 
circulating CRP concentration falls off rapidly at almost the rate of plasma CRP 
clearance.  
C-reactive protein (CRP) is a widely recognised indicator of inflammation.72 Recent 
prospective studies have demonstrated that increased CRP concentrations within the 
reference interval are an indication of myocardial infarction, stroke, sudden cardiac 
death and peripheral vascular disease in apparently healthy adults.63,73 On the basis of 
available evidence, the American Heart Association and the Centre for Disease Control 
(CDC) have issued guidelines for the utility of CRP in the primary prevention of 
coronary syndromes.68 The guidelines include specific recommendations that pertain to 
the laboratory aspect of CRP and defined cut-points for clinical interpretation: CRP 
concentrations <1 μg/mL (9 nM) are considered low, 1-3 μg/mL (9-27 nM) average and 
>3 μg/mL (>27 nM) high relative risk.68 Mild inflammation and viral infections 
generally cause CRP concentrations to increase to ~10-50 μg/mL (0.09-0.45 μM), 
whereas active inflammation and bacterial infections generally cause concentrations to 
increase to between 50-200 μg/mL (0.45-1.8 μM). Concentrations >200 μg/mL (>1.8 
μM) are seen in more severe infections and in trauma. 68 
CRP is now widely accepted as a biomarker for detection of possible onset of 
cardiovascular heart disease (CVD) as a result of increased levels of this protein 20, 21, 
23 with patients with a CVD disorder and/or myocardial infarction at the time of 
admission to hospital being noted to have CRP levels >3 µg/mL 23 the requirement now 
is therefore for point-of-care (POC) testing of CRP for risk stratification of coronary 
disease. It is important that a patient suspected of CVD must be diagnosed as quickly, 
effectively and comprehensively as possible, so it is crucial that the assay can be carried 
out quickly and hence at the POC, which would also enable on-going monitoring of a 
potential condition.  
CRP is therefore not only useful as a biomarker for evaluating inflammatory reactions, 
but also cardiovascular disease (CVD). Compared with other novel and traditional 
markers of coronary heart disease (CHD), CRP was shown to be the strongest predictor 
of future coronary events. High-sensitivity methods are therefore required for the 
measurement of CRP for the purpose of assessing risk of cardiovascular disease in 
apparently healthy individuals.  C-reactive protein (CRP) assay applications fall into 
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two main categories: low-medium sensitivity tests (> 6 µg/ml, 55 nM) e.g., latex 
agglutination tests, used for detection of an acute inflammatory response; and high 
sensitivity tests (< 1 µg/ml, 9 nM), e.g., ELISA (Enzyme-linked immunosorbent assay) 
or lateral flow tests. In routine clinical analysis, CRP levels are determined by ELISA 
tests. These assays are well established and detection limits down to 0.8 nM (0.1 
µg/mL) are available (Dade Behring Inc, now Siemens Medical, IL, USA).74  
1.8 Detection of C-reactive protein  
Expected merits relating to the performance of sensors include specificity, stability, 
sensitivity, range of detection, low cost and speed. With laboratory-based methods, 
many such factors are attained as standard and are therefore very reliable, consistent 
methods of detection. However, the emphasis is now shifting towards transferring 
sensing methods to point-of-care (POC) settings. Therefore speed, cost and portability 
should now be the prevailing issues while at the same time maintaining merits expected 
of biosensors such as specificity, stability and sensitivity.  
The latex agglutination test (LAT) is one of the earliest assay methods for sensing 
CRP.37 The method is still used today but is only semi-quantitative and insentitive, 
resulting in poor correlation with the clinical status of the patient.70 In the LAT and 
similar tests, biomolecularly specific antibodies are conjugated to latex microspheres 
which, when mixed with a solution (blood, urine) containing target antigen, cause the 
latex spheres to form visible aggregates (15 min to 1 hour).75  
Enzyme-linked immunosorbent assay (ELISA) is the gold standard in protein-based 
diagnostics. ELISA provides a quantitative, specific and sensitive approach, with 
excellent detection capabilities of 0.8 nM (0.1 µg/mL) and can be applied with the use 
of monoclonal antibodies specific to pCRP or mCRP for immunosensing. In 
conventional ELISA the signal generation mechanism consists of the chemical 
transformation of the enzyme substrate into a coloured or chemiluminescent product 
which is usually detected with a plate reader. This signal generation mechanism allows 
for the quantification of the target molecule because the colorimetric or 
chemiluminescent signal is proportional to the number of enzymes attached to the 
immunocomplex by means of the immunoreaction.43 However, ELISA is a 
heterogeneous assay requiring a number of manipulations (coating of plates with 
antibody, incubation with a sample, extensive washings, adding reagents for enzyme 
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amplification reaction and reading the signal) taking several hours to perform and 
requires trained personnel, expensive reagents and high sample and reagent 
consumption, as well as the disadvantage of a relatively high false positive rate due to 
non-specific bindings.70 This method is therefore not suitable for point-of-care health 
assessment.  
Lateral flow immunoassays are also commonly employed and use imaging processing 
algorithms specifically designed for a particular test and medium, whereby line 
intensities can be correlated with analyte concentrations. Sensing techniques that 
compete with ELISA and lateral flow assay but that offer faster and inexpensive 
diagnosis through POC systems are highly desirable. Therefore a plethora of novel 
detection techniques and applications for the detection of analytes of interest have been 
proposed. While many of these techniques eloquently demonstrate effective application 
of such techniques in laboratory settings, many factors pertinent to transfer of 
laboratory-based assays to point-of-care analysis are mostly not addressed.  
An “inverse sensitivity” approach has been applied to ELISA for detection of analytes 
at low concentrations, whereby the signal generated is larger at lower target molecule 
concentrations than at higher concentrations.76 This removes the ambiguity associated 
with differentiating slight variations of the same colour, enabling visual detection. 
However, the use of hydrogen peroxide solutions required in the reduction of gold ions, 
are unstable. 76 Non-specificity was evident linked to the number of incubation and 
washing steps. Lengthy assay times of hours are involved.77 Inverse sensitivity has also 
been applied to plasmonic nanosensors whereby the enzyme glucose oxidase is 
employed, but also involves lengthy assay times. 78  
Nanoparticle self-assembly offers an attractive alternative to traditional and lateral flow 
assay technologies and also many recently developed techniques. DNA has been 
successfully employed to organize nanoparticles into assemblies, representing much 
advancement in the field.79, 80 However, the interactions are sensitive to temperature 
changes which results in the requirement for active temperature control.81  Self-
assembly involving small DNA origami has been demonstrated but again temperature 
limitations are evidenced.82 Artificial proteins have also been designed 83, 84  and applied 
in the self-assembly of metallic colloids.85 By adjusting the ratio of protein to particles, 
the self-assembly could be tuned between formation of large films and smaller 
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nanoparticle nanostructures. Assay times of hours are involved. Analyte binding has 
previously been employed to prevent nanoparticle self-assembly. 86 In the presence of 
analyte molecules, which bind to the synthetic receptor, nanoparticle assembly is 
prevented. However, the approach is limited to one analyte molecule concentration and 
does not address a scenario whereby alternative concentrations may not result in the 
required coverage of receptors with analyte molecules to prevent aggregation.86 Surface 
enhanced raman spectroscopy (SERS) has also been employed in protein detection 87 
including single-spot multiplex protein detection. 88  Silver nanoparticle aggregates have 
also been employed in SERS detection of CRP 89, 90   
 
1.9 Surface-based detection of biomolecules 
A biosensor is derived from the coupling of a ligand-receptor binding reaction to a 
signal transducer. 91 Much biosensor research has been devoted to the evaluation of the 
relative merits of various signal transduction methods including optical,92 radioactive,93 
electrochemical,94 piezoelectric,95 magnetic,96 micromechanical 97 and mass 
spectrometric.98 Research in the field of biosensors was initiated by Clark, who 
designed a biosensor to detect the presence of oxygen.91 This was inspired by the 
critical need to monitor oxygen levels of patients undergoing surgery. Another huge 
area in biosensor technology is glucose detection. A modification of Clark’s biosensing 
system led to the first blood glucose sensing device, an area of diagnostics now 
dominated by sensors, starting with the first commercial approaches for glucose 
detection produced by Yellow Spring Instruments (YSI INC 1975).91 These earliest 
biosensors were catalytic systems that integrated particular enzymes with transducers 
that converted the biological response into an electrical signal. The next generation of 
biosensors, affinity biosensors, took advantage of different biological elements, such as 
antibodies, receptors (natural or synthetic) and nucleic acids. In all of these interactions, 
the binding between the target analyte and the immobilised biomolecule or the 
transduction element is governed by an affinity interaction such as the antibody-antigen, 
DNA – DNA or the protein-nucleic acid binding. The specificity of the biosensor is 
given by the immobilised molecule.91 The development of blood glucose control and 
monitoring technology has achieved significant progress over the last decade. This 
offers patients a means of real-time measurement of blood glucose level, thus improving 
their quality of life. Several commercial test kits have been employed in routine 
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diagnostic tools, including those utilising chemical strips and those used to test blood 
and urine levels by sampling specimens directly into the strip followed by visual 
reading of the colour charts. In 2006, the first real-time continuous glucose monitoring 
system, DexCom7 was approved by the FDA and in 2007 its lifetime was extended 
from 3 days to 7 days. The latest Continuous Glucose Monitoring System facilitates 5 
days of continuous glucose monitoring and was approved by the FDA in 2008. 99, 
100 The Clearblue Pregnancy Test is an example of a current sensing technology with a 
digital reader. It is over 99% accurate, reading “Pregnant” or “Not Pregnant” and also 
indicates how many weeks since conception occurred, 1 – 2, 2 – 3 or more than 3 weeks 
(3+) being as accurate as an ultrasound scan at dating pregnancy. 101 
Generally surfaces are chemically modified to better control the organisation and the 
orientation of immobilised species and therefore their biological function. Silicon 
surfaces attach alkylsilanes through the formation of Si – O - Si bonds between the 
silanol groups present on the oxidised silicon surfaces and the hydrolysed organosilane 
molecules. The presence of NH2 end groups on the surface has a major importance in 
biological application as it allows proteins or other molecules with carboxyl groups 
(functional groups that are commonly found in biomolecules) to be attached in a simple 
way. Trifunctional alkoxysilanes R-Si(OR)3 are the most common precursors to 
introduce organic groups because of the variety of such silanes commercially available 
– (3-Aminopropyl)triethoxysilane (APTES) being one of the most popular. APTES is 
widely used in affinity based biosensors because the silane group can tightly bind to 
silicon or glass substrates, while its amine group can form covalent bonds.102  
 
Figure 1.3: Structure of (3-Aminopropyl)triethoxysilane (APTES). 
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Various interfacial processes may be possible (covalent binding to the surface, lateral 
polymerisation of adsorbed silanes, 3D polymerisation).103,104,105,106  Silane grafting is 
expected to occur in two steps in the presence of water molecules, firstly the ethoxy 
groups are hydrolysed either in the liquid phase or at the interface, depending on the 
experimental procedure. Secondly the Si-O-Si bonds are formed with surface silanol 
groups. However these processes are difficult to evidence and strongly depend on the 
hydration state. The silane layer may be unstable in the aqueous media used for 
biological applications - partial hydrolysis of the siloxane bonds may cause 
desorption.107 Hydrogen bonding interactions with surface silanols alone result in 
weakly attached silane molecules on silica surfaces. APTES is an aminosilane and has 
three ethoxy groups per molecule and is capable of polymerising in the presence of 
water which can give rise to a number of possible surface structures. It is necessary to 
have water at the interface to form APTES multilayers in organic solvents and the 
number of protonated amine and hydrolysed ethoxy groups in the silane layers depends 
on the amount of surface water present. In general, anhydrous solvents with a trace 
amount of water and low silane concentration are desirable for the preparation of 
smooth APTES-derived silane layers. Solvent rinsing procedures and drying methods 
are also critical to the quality of monosilane layers.  
Drying procedures have therefore been used to ensure that covalent bond formation 
proceeds through condensation of hydrogen bonded silanol groups and have been 
carried out under a nitrogen stream under vacuum or in an oven. During heat curing, 
silanes condense very rapidly to siloxanes. Curing increases the number of siloxane 
bonds in the APTES films up to a max of three and can be carried out at ambient or 
related temperatures. Mild curing results in binding of the first half of the monolayers to 
the silicon and the remaining absorbed or partially polymerised APTES is therefore 
removed quickly. Curing is optimised in the presence of surface water and at curing 
temperatures greater than 150ºC. Consensus has been that chemical bonding between 
silane molecules and silica surfaces is necessary to ensure hydrolytic stability of 
attached silane layers as hydrolysis of the Si-O-Si linkages can occur under certain 
conditions.108 These procedures are necessary as hydrolytic stability of the attached 
aminosilane layers is vital for applications in aqueous media.  
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1.10 Electrical characterisation of antibody-antigen binding 
Materials on the nanoscale not only display strikingly different optical, chemical and 
magnetic properties but unique electrical properties also, compared to those of their 
macroscopic counterparts. Methods for immobilising probe protein on solid supports 
range from covalent binding and affinity ligand capture, to simple physical absorption. 
If a protein is immobilised on the surface of an electrode pair, it introduces a 
capacitance component in the impedance response of the sensor. This originates from 
the low dielectric permittivity of the immobilised macromolecule. Further, when the 
pair of modified electrodes is exposed to another protein that couples to the immobilised 
protein, a complex is formed. The dielectric layer covering the electrode will thicken 
resulting in a corresponding decrease of the sensor capacitance. The capacitance is 
determined by the thickness and dielectric properties of the insulating layer and the 
solid/solution interface both of which constitute the dielectric. Electrochemical 
impedance and capacitance biosensors have been employed to study antibody-antigen 
binding and protein binding at surfaces and demonstrate much potential as a point-of-
care sensing means. Capacitative immunosensors are made of successive layers 
deposited on a solid support. Each immobilised layer must have suitable electrical 
properties and the recognition element must retain its activity. Small capacitance 
changes might be expected for antibody-antigen recognition without amplification. The 
sensitivity is given by the ratio of change of the total capacitance Ct to the change in 
capacitance Ca due to the antigen binding. The sensitivity tends to 1 when Ci is large 
compared to Ca. This means that a change due to the binding of antigen will produce a 
maximum change in the sensor output when the initial capacitance, formed by the 
insulating layer and the antibody layers, is very large. 109 The capacitance of the 
antibodies depends on properties that cannot be used as design parameters. The only 
parameter left to be optimised, from a design point of view, is the thickness of the 
insulating layer. In order to have a maximum capacitance this layer should have a 
minimum thickness and be non-porous and non-soluble.  
 
 
____________________________________________________________________Chapter 1 
 
23 
 
1.11 Nanoparticle amplification 
Due to the low intrinsic signal of biomolecules the binding of antigen to antibody 
results in small and extremely localised conformational and charge related changes in 
the antibody structure which have proven difficult to measure with sufficient sensitivity 
and selectivity. A tracer is therefore often used to generate a signal for example, optical, 
electrochemical, or radioisotopic decay, which enables quantitation of the amount of 
bound antigen. There are many types of label used to monitor the antibody-antigen 
binding reaction including particles, metal and dye sols, radionuclides, enzymes, 
substrates and co-factors and electrochemically active compounds. The number of target 
molecules can then be converted to a specific measure. Traditionally radioisotopes and 
fluorophores have been used but challenges relating to poor stability, low sensitivity and 
difficult sample processing exist. The need for simple and reliable detection methods 
has led to the development of various inorganic nanoparticle-based probes, 
incorporating the remarkable magnetic, optical or plasmonic properties as previously 
described. This has resulted in much diversity in the scope of bioassays.110, 111 
Dielectrophoresis can be utilised as a means to position nanoparticle labels between 
electrodes for electrical characterisation. Dielectrophoresis is the translational motion of 
neutral matter caused by polarisation effects in a non-uniform electric field. 112 Uniform 
electric fields will exert force upon a charged particle and a neutral particle will be 
polarised but will not move relative to the electrodes.  However, non-uniform electric 
fields also exert force on neutral particles.  A neutral particle in a non-uniform field will 
still be polarised with both charges being equal, however, the field acting on these 
charges is not equal and therefore a net translational motion will result, with the particle 
either moving to or away from the region of highest field. The dielectrophoretic force 
experienced by a particle is dependant on the particle radius, the dielectric constant of 
the suspending medium, the root-mean-square of the electric field amplitude, the 
angular frequency and the real part of the Clausius-Mossotti factor which considers the 
complex permittivities of the particle and the medium. Negative dielectrophoresis, i.e. a 
particle is repelled from the region of highest field, occurs when the real part of the 
Clausius-Mossotti factor is negative.  Conversely, if the real part of the Clausius-
Mossotti factor is positive then positive dielectrophoresis occurs, i.e. the particle is 
attracted to the region of highest field. In the case of gold nanoparticles suspended in 
water the real part of the Clausius-Mossotti factor is always positive for frequencies 
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below 1018 Hz. 113  The permittivity of gold nanoparticles is larger than that of bulk gold 
partly due to their small size and partly due to the interfacial charge layer that is used to 
stabilise them.  Increasing the conductivity of the solution and/or increasing the 
effective permittivity of the particle can lower the crossover frequency from positive to 
negative dielectrophoresis. 
 
Considerable effort is being made to overcome the limitations of conventional bioassays 
by developing biosensors that can provide continuous in situ and rapid measurement of 
biomolecular activity in clinical diagnostics. Point-of-care (POC) devices capable of 
comprehensive diagnosis would decrease dramatically the time period involved from 
blood collection to analysis. This is of prime importance when assessing health 
conditions that can rapidly occur and worsen, for example, rapid diagnosis of heart 
problems is crucial to administer the appropriate treatment and to increase the chances 
of survival of the patient. Monitoring the evolution of the disease requires the analysis 
of cardiac markers to be performed periodically, therefore need for fast and accurate 
POC devices for detecting cardiac markers and more generally for detecting markers 
relevant to diseases that can evolve rapidly in varying circumstances.  
 
POC testing for CRP at a GP surgery or hospital is therefore advantageous, in addition 
to testing at a range of near-patient settings, for example, at a patient’s home. POC 
sensing at a GP surgery or hospital can improve clinical decision-making, patient 
management and referrals (urgent, non-urgent), monitoring and management of 
conditions with potential impact on mortality and morbidity. It facilitates provision of 
an immediate result and rapid decision-making and an improvement of care for remote 
practices. A high degree of accuracy is required in addition to the need for quality 
control, calibration and maintenance, and the means to transfer and integrate the result 
within the clinical records system. Whereas POC testing for certain diseases and 
conditions is feasible at a patient’s home or near-patient setting, for example CRP, 
utilising visual semi-quantitative detection means which can facilitate provision of an 
immediate result and also monitoring of ongoing potential conditions which can then 
direct appropriate medical care. The use of a patient’s mobile phone can alternatively 
communicate test data via a smartphone app electronically to a testing facility such as a 
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hospital laboratory for analysis following which the result can be provided to the patient 
electronically, eliminating the requirement for frequent attendance at a GP surgery or 
hospital setting to monitor such conditions. 
Sensing technology should be sensitive, cost effective, lightweight, selective, rapid, 
inexpensive, easy to fabricate, user friendly and biocompatible. 114  The first biosensing 
application of gold nanoparticles was the pregnancy test developed in 1976 115 in which 
the functionalization of the nanoparticles with specific antibodies provided their 
anchoring at the test window while their extremely high extinction coefficient provided 
sufficient signal in the colorimetric detection of the human gonadotropic hormone. The 
pregnancy test has not seen any innovation in over 30 years with the exception of 
adding a digital component. US start-up Lia has developed an FDA approved flushable 
and biodegradable pregnancy test. 116 As with other over-the-counter pregnancy tests it 
looks for the presence of human chorionic gonadotropin in urine. It is a colorimetric test 
relying on visual detection – one red line for a negative result and two red lines for a 
positive result and is over 99% accurate. It is engineered from paper and not plastic 
having special perforations to help the test break down easily when flushed or 
composted. It provides for a more private, convenient alternative for pregnancy testing 
reducing patient anxiety while also creating a more environmentally friendly alternative 
to the plastic methods currently on the market. Plastic accounts for approximately 52% 
of the cost of such tests. The global market for at home pregnancy and ovulation testing 
is at over $900 million. 116 Such a visual detection method is a most attractive detection 
method to enable rapid detection of analytes of interest at the point-of-care.  
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1.12 Scope of the thesis 
The scope of this thesis is the exploration and characterisation of solution phase and 
surface-based binding of C-reactive protein (CRP) antigen to CRP antibody for the 
purpose of determination of the potential of visual threshold point-of-care detection of 
CRP. It was required to determine if merits standard of laboratory-based CRP detection 
such as specificity, stability, sensitivity could be maintained in addition to incorporating 
rapidity, cost-efficiency and portability - merits expected of point-of-care sensors.  
Nanoparticle self-assembly is envisaged as an attractive technique for POC sensing of 
CRP. Metal nanoparticles have high indices of refraction and produce strong light 
scattering facilitating visual detection. A visual detection method, even if the result is 
only semi-quantitative (e.g. threshold detection) is a most attractive detection method to 
enable rapid screening of and timely intervention for treatment of diseases pertinent to 
our time, void of complex chemical processes and elaborate equipment. Employing just 
gold nanoparticles functionalized with CRP antibodies and CRP antigen linker 
molecules, solution-phase recognition-induced nanoparticle self-assembly was 
employed to discern if control of the rate of the self-assembly process could be achieved 
to enable rapid detection of CRP while maintaining specificity, stability and sensitivity 
facilitating application to POC sensing.    
Surface-based assays also show much promise in application to POC sensing. It was of 
interest to determine if surface-based assays void of complex chemical processes and 
elaborate equipment could compete with laboratory-based assays in terms of specificity, 
stability and sensitivity but also offer faster and inexpensive diagnosis. The binding of 
CRP antibody to silanised silicon-silicon oxide substrates implemented using the 
organosilane APTES and the subsequent binding of CRP antigen to this immobilised 
CRP antibody was explored. Electrical characterisation of the binding event of CRP 
antigen to surface immobilised CRP antibody in ambient conditions assessed the 
reaction occurring at the biosensor surface. The use of nanoparticles as tracers in 
surface-based assays was evaluated as a means to quantify the amount of bound antigen. 
The binding of CRP antigen to surface immobilised CRP antibody was marked by gold 
nanoparticles functionalised with CRP antibodies (antiCRP NPs) marking the presence 
of CRP antigen and analysed numerically employing imageJ to determine the 
sensitivity, speed of response and limits of detection of the method. 
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2.1 Introduction 
Nanoparticle self-assembly is envisaged as an attractive technique to facilitate point-of-
care (POC) detection of C-reactive protein (CRP). Metal nanoparticles have high 
indices of refraction and produce strong light scattering facilitating visual detection. A 
visual detection method, even if the result is only semi-quantitative (e.g. threshold 
detection) is a most attractive detection method to enable rapid screening of and timely 
intervention of CRP, void of complex chemical processes and elaborate equipment.  
To facilitate such POC detection, a rapid, inexpensive assay is required while 
concurrently maintaining such expected merits of biosensors such as specificity, 
stability and sensitivity. Many recently developed techniques for biomolecular detection 
focus on achieving lower and lower limits of detection, for example, 100 pg/mL, 17 
pg/mL and 1 fg/mL.1, 2, 3 However, these techniques are mostly not amenable to POC 
settings due to requirement for elaborate experimental techniques and/or equipment 4, 5 
or specific experimental requirements such as temperature control. 2, 6   
Employing just gold nanoparticles functionalized with CRP antibodies and CRP antigen 
as linker molecules, solution-phase recognition-induced nanoparticle self-assembly was 
employed to discern if control of the rate of the self-assembly process could be achieved 
to enable rapid detection of CRP while maintaining specificity, stability and sensitivity 
of the assay facilitating application to POC sensing of CRP.  
It was also of interest to discern if control of the rate of the recognition-induced 
nanoparticle self-assembly process could be corroborated employing nanoparticles of 
differing size and functionality. In that regard 60 nm citrate-stabilised gold 
nanoparticles were employed using Re2(DMAA)4(NCS)2  as linker molecules.   
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2.2 Experimental  
2.2.1 Formation and UV-visible characterization of NP-CRP assemblies  
UV-visible spectroscopic analysis was performed using an Agilent 8453 
spectrophotometer. All glassware and cuvettes were cleaned using aqua regia (3:1 
HCl:HNO3) to remove any metal residue and piranha solution (3:1 H2SO4:H2O2) to 
remove organic residue. Warning these solutions are very corrosive reacting violently 
with organic material and so must be handled with extreme care. Glassware and 
cuvettes were then rinsed thoroughly using ultrapure deionized water. UV-visible 
spectra were recorded of the phosphate buffered saline (PBS) solution and of the CRP 
antibody functionalized 40 nm diameter gold nanoparticle solutions (BBI Solutions) 
diluted to optical density 2 with Phosphate Buffered Saline solution. Aliquots of 
purified C-reactive protein (CRP) antigen solution (BBI Solutions) were added to the 
antibody functionalized gold nanoparticle solutions (BBI Solutions), equating to ratios 
of antigen linker molecules to nanoparticles of 2:1, 12:1, 18:1 and 72:1. Solutions were 
gently stirred with a magnetic stir bar. UV-visible spectra of these solutions were 
recorded in the wavelength range 400 nm < λ < 800 nm at time intervals of 2-10 
minutes. Resultant nanoparticle solution colour changes were visually observed over 
time.  
 
2.2.2 Determination of robustness and specificity of formation process  
Solution stability was investigated, employing UV-visible analysis as described above, 
whereby no CRP antigen solution was added to the CRP antibody functionalized 
nanoparticle solution and absorbance measured over a 5 hour time frame. Similarly 
robustness, where harsh stirring conditions were employed at a temperature of 50°C and 
specificity, where a goat anti-mouse antibody functionalized 40 nm gold nanoparticle 
solution was used in place of the monoclonal anti-human CRP antibody functionalized 
nanoparticle solution. It is required for the primary antibody (goat) to be raised against 
(anti) the species of the specimen, i.e anti-human. Goat anti-human CRP antibody 
recognizes human CRP. An aliquot of antigen solution was added equating to a ratio of 
antigen linker molecules to nanoparticle of 2:1. 
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2.2.3 Formation of NP- Re2(DMAA)4(NCS)2  assemblies  
Control of the rate of nanoparticle self-assembly process was corroborated employing 
citrate-stabilised gold nanoparticles and a di-isothiocyanate terminated metal organic 
rhenium linker Re2(DMAA)4(NCS)2. Citrate-stabilised gold nanoparticle solutions with 
nanoparticle core diameter of d = 60 nm were purchased from BBI. Ultrapure deionized 
water was used in all experiments. To improve the stability of the citrate-stabilised 
nanoparticle solutions, 3 mM aqueous tri-sodium citrate was added prior to use (1:1). 
The bi-functional linker molecule Re2(DMAA)4(NCS)2 was dissolved in acetone. UV-
Visible absorption spectra were recorded of these nanoparticle solutions using an 
Agilent 8453 spectrophotometer. 2 µL aliquots of 10 µM Re2(DMAA)4(NCS)2 linker 
solution were added to each of the nanoparticle solutions at 2 - 10 minute intervals, 
followed by mixing and recording of UV-visible spectra, in addition to visual 
observation of nanoparticle solution colour changes 
2.2.4 Scanning electron microscopy characterization of assemblies 
Aliquots of nanoparticle solution were removed at various intervals during each 
nanoparticle assembly formation experiment. Scanning electron microscopy (SEM) 
characterisation was performed (JSM-7500F JEOL UK Ltd) on these aliquots of 
solution following dilution by a factor of 100 and drop deposited on to individual 
silicon substrates (rendered hydrophilic by immersion in H2SO4 for 30 minutes 
followed by immersion in HCl : methanol (1 : 1) solutions for 30 minutes). For each 
substrate, at least 100 nanostructures were counted at random locations using the Step 
Function on the SEMs motorized stage. The numbers of each sized nanostructure 
formed for each time interval were recorded. These numbers provide the experimental 
concentrations of each sized nanostructure formed which are then used in a set of 
generation-recombination models and rate equations developed by Dr Nicolas Sassiat 
during his Ph.D. within the Nanotechnology Group at Tyndall. 7 This phenomenological 
model based on a system of rate equations (superseding an initial full random-walk 
approach) is implemented using MATLAB routines developed by Dr Sassiat. The 
model can accommodate and essentially fit the distributions of nanostructure 
populations found experimentally through SEM analysis and facilitates estimation of 
the enthalpies of reaction for molecular decoration of nanoparticle surfaces and 
nanoparticle association on the basis of the values of the optimised fit parameters. 
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2.3 Results and Discussion 
2.3.1 Formation and UV-visible characterization of NP-CRP assemblies  
C-reactive protein (CRP) antibody functionalized 40 nm diameter gold nanoparticle 
solution, diluted to optical density 2 with phosphate buffered saline, exhibits a single 
absorption peak in the UV-visible spectrum at λmax = 531 nm, see figure 2.1 (a) and a 
ruby red colour. It consists of highly dispersed single nanoparticles. Stability of the 
nanoparticle solutions and batch-to-batch variability is affected by the protein covering 
on the gold particle which acts to passivate the surface (i.e. prevent the salt collapse 
associated with citrate-capped particles). The amount of protein and the conformation 
on the surface will affect this, see figure 2.1 (b) whereby on dilution with PBS solution 
resulted in the collapse of the gold nanoparticle solution. The nature of the protein 
interaction with the gold surface and the storage buffer will also affect whether the 
protein remains on the particle surface during storage. The stability is however 
established on dilution of the nanoparticle solution with buffer and monitored over 
lengthy time intervals using UV-visible absorption spectroscopy, see figure 2.1 (a).  
 
(a) 
 
(b) 
 
Figure 2.1: UV-visible absorbance spectra recorded versus wavelength (λ) over 300 minutes, of C-
reactive protein (CRP) antibody-functionalised 40 nm diameter gold nanoparticle (a) stable solution to 
which no CRP antigen linker molecules have been added, (b) unstable solution to which no CRP antigen 
linker molecules have been added. 
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Directed assembly of CRP antibody functionalized gold nanoparticles occurred through 
addition of CRP antigen linker molecules. Concentrations of antigen linker molecules 
corresponding to nanoparticle-molecule ratios of 2, 12, 18 and 72 molecules per 
nanoparticle were used, see table 2.1.  
 
Volume & Concentration antigen Molarity (nM) # antigen molecules per NP 
10 µL @ 0.01 mg/mL 0.6 nM 2 
60 µL @ 0.01 mg/mL 3.6 nM 12 
9 µL @ 0.1 mg/mL 5.4 nM 18 
18 µL @ 0.2 mg/mL 22 nM 72 
 
Table 2.1: Table of 4 different concentrations of CRP antigen added to an optical density 2 antiCRP NP 
solution, with the corresponding solution molarity and average number of molecules available in solution 
per nanoparticle. 
 
The spectral signature of red-shifted and broadened absorption bands and two 
absorption maxima is ascribed to the assembly of nanoparticles forming nanostructures, 
see figure 2.2. UV-visible absorbance spectra recorded versus wavelength over 60 
minutes, representing nanoparticle-molecule formation where (a) 10 µL of 0.01 mg/mL 
CRP antigen solution is added to antiCRP nanoparticle solution @ optical density (OD) 
2 (0.6 nM, 2 molecules per NP), (b) 60 µL of 0.01 mg/mL CRP antigen solution is 
added to antiCRP NP solution @ OD 2 (3.6 nM, 12 molecules per NP), (c) 9 µL of 0.1 
mg/mL CRP antigen solution is added to antiCRP NP solution @ OD 2 (5.4 nM, 18 
molecules per NP), (d) 18 µL of 0.2 mg/mL CRP antigen solution is added to antiCRP 
NP solution @ OD 2 (22 nM, 72 molecules per NP). 
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Figure 2.2: UV-visible absorbance spectra recorded versus wavelength (λ) over 60 minutes where (a) 10 
µL of 0.01 mg/mL CRP antigen solution is added to antiCRP NP solution (0.6 nM; 2 molecules per NP), 
(b) 60 µL of 0.01 mg/mL CRP antigen solution is added to antiCRP NP solution (3.6 nM; 12 molecules 
per NP), (c) 9 µL of 0.1 mg/mL CRP antigen solution is added to antiCRP NP solution (5.4 nM; 18 
molecules per NP) and  (d) 18 µL of 0.2 mg/mL CRP antigen solution is added to antiCRP NP solution @ 
~OD2 (22 nM; 72 molecules per NP). 
 
The first peak located near the resonance peak for single nanoparticles is attributed to 
the transversal resonance peak/ plasmon excitation in coupled spheres. Overall the peak 
intensity at λmax (531 nm) decreases in magnitude as a result of the decrease in the 
number of single nanoparticles and is red-shifted by up to 4 nm and broadened over a 
time frame of 60 minutes. As nanostructures form, the emergence of a second peak is 
evident at ~ 600 nm. As nanostructure formation progresses, this second peak intensifies 
and shifts to longer wavelengths which reflects the increase in chain length and the 
linear nature of the assembly. Increase in the full width at half max (FWHM) of the new 
peaks is mainly explained by the increase in the number density leading to a branched 
network. This second longer wavelength peak arising from the formation of dimers and 
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higher order nanostructures has previously been predicted theoretically and observed 
experimentally using optical transmission measurements on fabricated and synthesised 
dimer nanostructures. The intensity of the aggregated system depends on the degree of 
aggregation as well as orientation of the individual nanoparticles within the 
aggregates.8,9,10  
The increase in the assembly degree was signified by a solution colour change from red 
to blue within 5 minutes when the concentration of linker molecules supplied in solution 
provided on average 2 linker molecules per nanoparticle, see figure 2.3 (b). The blue 
solution colour is ascribed to the formation of large nanostructures, see figure 2.2 (a) 
and figure 2.3 (a), facilitating visual detection of a CRP concentration of 0.06 µg/mL 
within 5 minutes. Nanoparticle- linker molecule ratios outside of a narrow range, for 
example, 12, 18, 72 resulted in only a vaguely discernable change in the tone of the red 
colored nanoparticle solution after 5 days, see figure 2.3 (d). Some decrease and red 
shift in absorbance was observed over long time intervals representing slow formation 
of small numbers of small nanostructures, see figure 2.2 (b) and figure 2.3 (c). As the 
number of CRP antigen linker molecules supplied in solution increases, the rate of 
formation of nanostructures decreases, see figure 2.2 (c) and (d) and figure 2.3 (c).  
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(a) 
 
(b) 
 
(c) 
 
(d) 
 
 
Figure 2.3: UV-visible absorption spectra of C-reactive protein (CRP) antibody functionalized 40 nm 
diameter gold nanoparticle solution to which (a) CRP antigen linker molecule-nanoparticle ratio = 2:1 and 
(c) CRP antigen linker molecule-nanoparticle ratio = 18:1. Corresponding photographs of C-reactive 
protein antibody functionalized 40 nm diameter gold nanoparticle solution taken (b) prior to addition of 
CRP antigen and 5 minutes following addition of CRP antigen solution (2:1), (d) prior to addition of CRP 
antigen and 5 days following addition of CRP antigen solution (18:1). 
 
Of critical significance in any assay platform is determination of the range of detection 
for the particular analyte. In this technique employing 40 nm gold nanoparticles, the 
range of detection is limited by the number of CRP antibody molecules bound to the 
nanoparticle surface and also by the number of nanoparticles present, allowing a 
maximum number of molecules to bind to all available nanoparticles, irrespective of the 
quantity of molecules in solution. However, in the case of binding of molecules to all 
available CRP antibody molecules, nanostructure formation is prevented as an antigen 
shouldn’t bind to an antigen. For nanostructure formation to occur there must be a 
nanoparticle/nanostructure which has an available antibody on its surface to which no 
antigen is bound, another nanoparticle/nanostructure which has an antigen bound to a 
surface attached antibody and a collision event of the surface bound antibody with the 
antibody bound antigen. When many of the nanoparticle antibody binding sites have 
been occupied with antigen linker molecules nanostructure formation is limited to slow 
formation of small numbers of small nanostructures, as is the case when the molecule-
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nanoparticle ratio is 12 or greater, see figure 2.4 (c). It was found however when the 
molecule-nanoparticle ratio was 2:1 rapid formation of large numbers of large 
nanostructures occurred, facilitated by many available antibody binding sites on the 
nanoparticle surfaces and sufficient antibody bound antigen on the nanoparticle surface 
to facilitate rapid formation of large nanostructures, see figure 2.4 (b). Therefore, the 
upper limit of detection is actually lower than the maximum permittable number of 
antigen molecules that can bind per nanoparticle. This facilitates naked eye detection of 
CRP antigen that falls within certain concentration ranges: if the CRP antigen 
concentration falls within the upper limit of detection (LOD) (as determined by NP : 
molecule ratio) a rapid solution colour change from ruby red to blue will occur within 5 
minutes. However, if the concentration is close to or much higher, this colour change is 
not seen. The possibility for detection across a range of CRP concentrations is 
facilitated by varying the number of nanoparticles present in the assay or the sample 
volume.   
 
(a) 
 
(b) 
 
(c) 
 
(d) 
 
(e) 
 
 
(f) 
 
Figure 2.4: Schematics depicting the relative coverage of the antiCRP NPs  with CRP antigen (a) antigen 
molecule-NP ratio = 0:1, (b) antigen molecule-NP ratio = 2:1  (c) antigen molecule-NP ratio = 18:1 and 
corresponding SEM images in (d), (e) and (f). SEM image scalebars = 120 nm. 
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2.3.2 Determination of robustness and specificity of formation process  
The robustness of the nanostructure formation process was then investigated. An 
elevated temperature (37°C) was employed to check the stability of the antiCRP 
nanoparticle solution, i.e. if an elevated temperature was having a significant impact on 
the speed of formation of nanostructures.  Figure 2.5 displays UV-visible absorption 
spectra recorded for the formation of nanostructures using CRP antibody functionalised 
gold nanoparticle solution to which 9 µL 0.1 µg/mL CRP antigen was added – the 
nanostructure formation process being carried out at temperatures of (a) 25°C (b) 30°C 
(c) 37°C and (d) 40°C. 
 
  
  
Figure 2.5: UV-visible absorbance spectra of antiCRP nanoparticle solution @ ~OD2 to which 9 µL of 
0.1 mg/mL CRP antigen solution is added, recorded versus wavelength (λ) over 60 minutes, representing 
nanostructure formation at (a) 25°C (b) 30°C (c) 37°C and (d) 40°C. 
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Temperatures of 37ºC – 40ºC resulted in an increased rate of nanostructure formation, 
however, not to the extent that even after 60 minutes the colour change is not 
appreciable enough to detect with the human eye, i.e. at elevated temperatures of 37°C 
the solution still remained red days following addition of antigen linker molecules. 
Increased temperatures did not result in any adverse effects on the solution at an 
elevated temperature. Repeatability was also ascertained, see figure 2.6. 
 
 
Figure 2.6: UV-visible absorption spectra, recorded versus wavelength over time, of two different C-
reactive protein (CRP) antibody functionalized 40 nm diameter gold nanoparticle solutions, where the 
ratio of antigen linker molecules to nanoparticle is 18:1, performed at 20°C and two different C-reactive 
protein (CRP) antibody functionalized 40 nm diameter gold nanoparticle solutions where the ratio of 
antigen linker molecules to nanoparticle is also 18:1, performed at 37°C. 
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A control experiment was also carried out in parallel, to which no CRP antigen was 
added to determine the stability of the antiCRP NP solution at an elevated temperature 
of 37ºC, with harsh stirring, see figure 2.7. 
 
 
Figure 2.7: UV-visible absorption spectra recorded versus wavelength over time of C-reactive protein 
antibody functionalized 40 nm diameter gold nanoparticle solutions to which no CRP antigen linker 
molecules were added and where harsh stirring conditions at 37°C were employed.  
 
Also gold nanoparticles functionalized with goat anti-mouse antibodies were used in 
place of CRP antibodies, see figure 2.8. In this case the number of antigen linker 
molecules per nanoparticle was also 2:1. Results demonstrated no red-shift of 
absorbance maxima to longer wavelengths or decrease in intensity. These results 
therefore ascertain robustness of the CRP antibody functionalized nanoparticle solutions 
to environmental conditions and specificity, with regard to nanoparticle self-assembly, 
i.e. dependence on presence of CRP antigen linker molecules to formation of 
nanostructures. 
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Figure 2.8: UV-visible absorption spectra recorded versus wavelength over time of a goat anti-mouse 
antibody functionalized 40 nm diameter gold nanoparticle solution (used in place of C-reactive antibody 
functionalized gold nanoparticle solution) where the ratio of antigen linker molecules to nanoparticle is 
2:1.  
 
 
2.3.3 Formation of NP- Re2(DMAA)4(NCS)2  assemblies  
Such control of the nanoparticle self-assembly process can be applied across different  
nanoparticle sizes and functionality as was additionally demonstrated employing 60 nm 
citrate-stabilized gold nanoparticle solution and Re2(DMAA)4(NCS)2  linker molecules, 
which are ~1.2 nm in diameter as compared to the CRP antigen linker molecules which 
are ~ 11 nm in diameter.  In this case many more Re2(DMAA)4(NCS)2  linker 
molecules were required to replace the strong carboxylate-terminated citrate protectors. 
Supplying 1000 Re2(DMAA)4(NCS)2  linker molecules per nanoparticle resulted in 
rapid nanoparticle assembly accompanied by a distinct solution color change, see figure 
2.9 (a) while 14000 Re2(DMAA)4(NCS)2  linker molecules per nanoparticle resulted in 
slow/restricted nanostructure formation, see figure 2.9 (b). 
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Figure 2.9: UV-visible absorption spectra, recorded versus wavelength over time, of citrate stabilized 60 
nm diameter gold nanoparticle solutions to which (a) the ratio of Re2(DMAA)4(NCS)2 linker molecules 
to nanoparticle is 1000:1 and (b) the ratio of Re2(DMAA)4(NCS)2 linker molecules to nanoparticle is 
14000:1. 
 
2.3.4 Scanning electron microscopy characterization of assemblies 
Scanning electron microscopy (SEM) is an excellent tool for the morphological study of 
nanoparticles and their assemblies but any solution must be dried onto a substrate before 
inserting into the SEM vacuum chamber. This drying process could possibly change the 
state of the solution species by inducing aggregation, dissociation or reorganisation 
which can add to ambiguities when interpreting SEM images. 
To reinforce the UV-visible findings and ensure that the original solutions, on dilution 
with PBS solution, are composed of mostly monomers, aliquots of these solutions being 
analysed by UV-visible spectroscopy were removed at intervals for SEM analysis. To 
obtain reliable statistics of the nanoparticle/nanostructure population within a solution 
and also elimination of formation of nanostructures as a result of drying effects, the 
aliquots of solution removed from the diluted antiCRP NP solution under analysis were 
diluted by a factor of 100 to ensure a dilute sample and hence good spacing between 
nanoparticles/nanostructures deposited on the substrate. Individual silicon chips 
(substrate resistivity ~5 mΩcm) were used as substrates for SEM analysis. These 
substrates were rendered hydrophilic by immersion in H2SO4 and HCl : methanol (1:1) 
solutions for 30 minutes each. This ensured that the drop of solution spread out evenly 
over the substrate increasing the distance between nanostructures at the substrate 
surface. Single 50 µL drops of solution were deposited on each silicon chip. The excess 
solution was then wicked away by placing filter paper at the edge of the chip. The 
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remaining solution was allowed to air dry on the substrate and when dry, the substrate 
was rinsed in ultrapure deionised water and gently dried under a stream of nitrogen.  
Following drop deposition and SEM imaging, manually counting the numbers of 
nanoparticles/nanostructures to obtain number populations of the various classes of 
nanostructures present was carried out. This illustrates that a dilution factor of 100 of 
the conjugate with PBS buffer resulted in close to 98% monomers, with only 3 dimers 
being present out of 162 nanostructures counted, thereby confirming that dilution of the 
antiCRP NP solutions with PBS solution and the drop deposition technique employed to 
prepare samples for SEM analysis did not result in the formation of “false” 
nanostructures and so is not only a suitable technique to confirm the stability of the gold 
conjugate upon dilution with PBS solution but also the drop deposition procedures used 
for preparation of SEM samples are suitable for application in quantifying the 
distribution of different classes of nanostructures formed via antibody-antigen 
recognition induced self-assembly on addition of CRP antigen to the gold conjugate 
solution. In order to quantify the distribution of nanoparticles and nanostructures on 
each individual substrate, representing the numbers formed at the various time intervals, 
SEM (JSM-7500F, JEOL UK Ltd.) was employed to record and statistically analyse the 
populations of monomers, dimers and higher order nanostructures.  
For each substrate, at least 100 nanostructures were counted at 20+ random locations as 
determined using the “Step function” on the SEM’s motorised sample stage, resulting in 
no more than 5  nanoparticles/nanostructures counted in each SEM image of area ~ 6 
µm x 4.75 µm. Each image was inspected manually to count and thereby obtain the 
distribution of the different classes of nanostructures present for each image. Using the 
table of records for each sample, the mean value for each class is calculated. Figure 2.10 
shows a typical SEM image containing dimers and a trimer. The histograms in figure 
2.11, display the % of nanostructures containing each number of nanoparticles (NP) up 
to 10 NP per NS for the various time intervals for three repeat nanostructure formation 
experiments.  
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Figure 2.10: Typical scanning electron microscopy image used to determine the distribution of 
nanoparticles and nanostructures formed at various time intervals during the nanostructure formation 
process. 
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(a) 
 
(b) 
 
(c) 
 
(d) 
 
(e) 
 
(f) 
 
(g) 
 
(h) 
 
(i) 
 
(j) 
 
 
Figure 2.11: Histograms showing the distribution of nanostructures (NS) containing (a) one (b) two (c) 
three (d) four (e) five (f) six (g) seven (h) eight (i) nine (j) ten NP  at various time intervals, present in the 
antiCRP NP solution following addition of 9 µL of 0.1 mg/mL CRP antigen solution (9 µL @ 0.1 
mg/mL, 5.4 nM, 18 M:NP). 
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The histograms show the nanostructure distribution for each class of nanostructure 
based on numbers of the different classes of nanostructures manually counted from 
aliquots of solution drop deposited on substrates. Over 500 SEM images were taken 
across 21 substrates, with a minimum of 100 nanostructures counted at random 
locations for each substrate. It can be seen that a gradual decrease in the numbers of 
monomers occurs from 98% at the beginning of the nanostructure formation process to 
just 44% after 60 minutes. This correlates with the decrease in intensity of the 
transversal peak for the solution of gold nanoparticles as recorded with the UV-visible 
spectrophotometer.  
After 10 minutes 15% of a total of 20% dimers have formed; 5% of a total of 12% 
trimers; 4% of a total of 8% nanostructures containing 4 nanoparticles and 1% of a total 
of 5% nanostructures containing 5 nanoparticles and after 20 minutes 19% of a total of 
20% dimers have formed and 11% of a total of 12% trimers being formed. Formation of 
nanostructures containing 6, 7 and 8 nanoparticles emerges 20 minutes after 
commencement of the experiment, nanostructures containing 9 nanoparticles at 30 
minutes and nanostructures containing 10 nanoparticles at 50 minutes with much less of 
them being formed and their formation being relied on more complex processes such as 
dissociation and formation of smaller clusters into larger ones. These results indicate 
that lower order nanostructures are eventually consumed in formation of higher order 
nanostructures which again correlates with the observations of the UV-visible analysis 
where a second peak at longer wavelength emerged as longer and branched chain 
nanostructure were formed. 
These results are synopsised in figure 2.12 where prior to addition of CRP antigen 98% 
of nanostructures observed were single nanoparticles, see figure 2.12 (a). SEM analysis 
revealed that when the linker molecule: NP ratio = 2:1, 5% observed nanostructures 
were single nanoparticles with 78% nanostructures comprising 10 or more 
nanoparticles, see figure 2.12 (b) and when the linker molecule :NP = 18:1 18% 
observed nanostructures were single nanoparticles and only 4% nanostructures 
comprising 10 or more nanoparticles, see figure 2.12 (c).  
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Figure 2.12: Scanning electron microscopy (SEM) analysis revealed that (a) 98% of nanostructures 
observed were single nanoparticles when linker molecule: NP = 0:1; (b) 5% observed nanostructures were 
single nanoparticles with 78% nanostructures comprising 10 or more nanoparticles when linker molecule: 
NP = 2:1, (c) 18% observed nanostructures were single nanoparticles and only 4% nanostructures 
comprising 10 or more nanoparticles when linker molecule :NP = 18:1.  
 
One step further towards realising the benefits of formation of such assemblies involves 
modelling/simulation of the processes involved in the growth of these nanoparticle-
biomolecule assemblies. This can, in part at least, be achieved by modelling the 
interactions in bulk solution between the nanoparticles and the molecules. Dr. Nicolas 
Sassiat developed a set of generation-recombination models and rate equations to do 
this. This section describes in brief and employs these set of rate equations to extract 
information pertaining to the growth of these assemblies over time in a given set of 
experimental conditions. 
Modelling of the nanostructure formation process is not an easy task owing to the large 
number of parameters influencing this mechanism. The phenomenological model 
developed by Dr. Sassiat, based on a system of rate equations (superseding the initial 
full random-walk approach), see figure 2.13, captures many of these processes 
influencing the formation of nanostructures. The system of rate equations presented is 
of first order but non-linear. The high flexibility of the model, implemented using 
MATLAB routines developed by Dr Sassiat, allows for accounting of molecular 
decoration of nanoparticle surfaces quantitiatively, whereas effects like perturbation of 
the double layer around nanoparticle surfaces or solvation issues are qualitatively 
considered. 
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Figure 2.13: Equation for a three species system. 7 
 
On commencement of the nanostructure formation process, within the cuvette there are 
monodisperse nanoparticles, as demonstrated from control experiments and SEM 
counting statistics. In order to model the formation of nanostructures we need to know 
the numbers of nanoparticles and molecules present and thereby the concentrations of 
each at any given time. As the quantity and optical density of antiCRP NP solution and 
quantity and concentration of CRP antigen solution added to the cuvette is known, a 
good estimate of numbers of both nanoparticles and molecules present is therefore 
known. Thereby the concentration of each can be calculated (number normalised by the 
volume). As described earlier in the chapter, aliquots of solution are removed for SEM 
analysis during the experiment and also an aliquot of CRP antigen solution is added at 
the beginning. Even though these quantities are µL volumes (tiny) they are still taken 
into consideration when calculating concentration of the nanoparticles and molecules at 
various time points during the experiment. Therefore the number of nanoparticles and 
molecules at any time point in the experiment can be described. Mixing of the solution 
results in what should be an homogenous dispersal of both entities, so it is assumed that 
the distribution of nanoparticles and molecules is evenly dispersed, on average at all 
times.  
These nanoparticles and molecules are moving around randomly. Locally self-diffusion 
exists due to the thermal energy carried by nanoparticles and molecules as described by 
the concept of random walk. In place of an analytical solution, Dr Sassiat utilised 
random walk simulations to estimate the rate of encounter of nanoparticles and 
molecules. The concept of random walk is widely used to model Brownian motion. 
Other factors governing the movement and transport of these nanoparticles and 
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molecules include diffusion and associated diffusion coefficients. Dr Sassiat addressed 
the classic Stokes Einstein relation to get an initial value for the translational diffusivity 
of 20 nm gold nanoparticles immersed in an aqueous solution. It is proportional to the 
thermal energy, inversely proportional to both the dynamic viscosity of the medium, 
and the hydrodynamic diameter of the diffusing nanoparticles taken as the nanoparticle 
diameter of 20 nm. The diffusivity of the molecules was accounted for by estimation 
according to values reported in literature for other molecules, which is accurate 
provided that the molecular mass is the leading term.  
At the start the assemblies are simple single 40 nm nanoparticles. However, as dimers, 
trimers and higher order nanostructures form, the size and shape and therefore their 
diffusivity differs considerably. Ideally we need to know what the diffusivity is for any 
of the nanostructures involved. Dr. Sassiat employed a simple trend law employing 
geometric arguments based on nanostructure shapes observed.  
So at the beginning there are just nanoparticles in the cuvette. CRP antigen molecules 
are then added and mixing results in an homogeneous mix of nanoparticles and 
molecules. In order for nanostructures to form, molecules need to collide with and bind 
to the nanoparticle surfaces. After collision, there are other factors which govern the 
propensity of a molecule to attach to the surface, such as the number of available 
binding sites on the surface, the number of available molecules in the pool and the 
adsorption rate constant. There are limited available binding sites on the surface of the 
nanoparticles, as determined by the number of CRP antibodies attached on the surface 
of the nanoparticles.  
Modelling of the formation of nanostructures incorporates the processes of two 
mechanisms: molecules adsorbing and desorbing from nanoparticle surfaces and the 
association and dissociation of molecule bearing assemblies. The reverse reaction does 
not rely on a collision event. So nanoparticle growth implies four elementary rate 
coefficients: molecular linker coverage of a nanoparticle surface, ha and molecular 
desorption from a nanoparticle, hd, association of two clusters via linker molecules, 
driven by the coefficient ka and dissociation of a cluster, driven by the coefficient kd , 
see figure 2.14. Variations in populations of nanostructures are influenced by the 
balance between gains by the aggregation of lower order nanostructures or the 
dissociation of higher order nanostructures. 
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Figure 2.14: Schematic (not to scale) of the four elementary steps involved in nanostructure growth. In 
the chemical equations, nc, ml and cl stand for nanoparticle, molecule and cluster, respectively. 7 
 
Once molecules begin to attach to the nanoparticle surfaces nanostructure formation can 
then commence. The formation of nanostructures does not require full coverage with 
molecules. In fact full coverage on all nanoparticles should prevent formation of 
nanostructures as all antibody binding sites would be occupied by antigen, which 
shouldn’t bind to another antigen. When nanoparticles or nanoparticles and 
nanostructures collide, two situations accommodating the efficiency of 
binding/aggregation can be described: there is at least one CRP antigen molecule bound 
to the surface attached CRP antibody, or molecular stacking impedes the binding based 
on steric factor. Therefore a description of the influence of molecules in the system is 
incorporated in the rate constants. Rate constants can be split into three main 
components: the attempt frequency, Z, the likelihood of the reaction due to potential 
steric factor, S and the exponential factor due to the energy barrier to be overcome, W. 
Once in contact with the surface, anchoring is the next step, governed by anchor groups 
and recognition-induced effects. Once anchored the second step involves molecular 
rearrangement driven by intermolecular interactions. It is of interest to determine what 
the limiting process in the reaction is. Either the molecules are limiting and so the 
attempt frequency is not too often or the energy barrier to be overcome is limiting.  
In order to model what is happening during the nanostructure formation process as 
described earlier in the chapter, we need to extract the numbers of different 
nanostructure types formed at various time points during this process. There are two 
ways of achieving this: firstly UV-visible spectroscopic analysis employing the Beer 
Lambert law which states that the absorbance is equal to the extinction coefficients 
multiplied by concentration and path length. However, to build the modelled spectrum 
of pure nanostructures, their extinction coefficients are required to be determined. The 
____________________________________________________________________Chapter 2 
 
59 
 
extinction coefficients of pure monomers are obtained by recording the UV-visible 
spectrum of a solution of monodisperse nanoparticles before any modification. 
Generalised Multiple Mie (GMM) method to investigate the optical response (extinction 
cross-section) of clusters of spherical particles was employed by Dr. Gaetan Leveque, 
former researcher at Photonics Theory Group, Tyndall, to simulate the optical spectrum 
of dimers. However, at present it is not possible to get the experimental spectrum of 
individual higher order nanostructures, since there is no reliable technique to achieve 
mono-dispersed samples of such species and simulations based on Mie theory have the 
disadvantage that the computation of spectra becomes ever more complicated with 
higher order nanostructures.  
For this reason, in this case, only population data is extracted from SEM counting 
statistics. A lengthy counting routine is performed manually on the SEM images taken. 
The numbers of nanostructures for each class is recorded for each image, as previously 
described. Using the table of records of each sample, the mean value of each class of 
nanostructures observed is calculated. The accuracy of the calculated concentration is 
subject to the maximum number of nanostructures taken into account. Choosing an 
unrealistically small value would introduce a bias in the statistics but a sufficiently large 
value ensures relevance to the family of concentrations. Compared to the Beer Lambert 
law fit, the analysis of SEM sample images offers the possibility of estimation of a 
broader range of entities that may be formed. Nanoparticle assemblies comprising up to 
~10 nanoparticles can be counted for high accuracy.  
The principle of curve fitting is based on comparing the locus of a suggested curve to 
the curve of the raw data. The difference between suggested points and measured points 
needs to be minimised, resulting in an R2 value close to 1. The parameters which result 
in giving the best “fit” to the experimental data are outputted along with a graphical 
representation of the fit versus the experimental data. Experimental concentrations of 
nanostructures estimated for each time interval are represented by the red circles and the 
best fit curve by green circles. The energy barrier to be overcome is considered, 
originating from the concept developed in Arhennius’ law, k = Ae-Ea/(kBT), where k = 
rate constant, A = pre-exponential factor, Ea = activation energy, kB = Boltzmann 
constant and T = absolute temperature in Kelvin, see figure 2.15. The corresponding 
activation energies can then be calculated so as to provide a value for the enthalpy of 
molecular binding and nanostructure formation, ∆H = Ea – Ed. 
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Figure 2.15: Energy diagram of the molecular decoration of nanoparticle surfaces and cluster formation 
along the reaction coordinate. 7 
 
It is shown that the model can accommodate and essentially fit the distributions of 
nanostructure populations found experimentally through scanning electron microscopy 
analysis, see figure 2.16. The corresponding activation energies can then be calculated 
so as to provide a value for the enthalpy of molecular binding and nanostructure 
formation, ∆H = Ea – Ed, see table 2.2. These estimates indicate that the enthalpies of 
both processes are negative and so the reactions are exothermic. This indicates that a 
system comprising a linker molecule and a bare nanoparticle has its energy lowered 
when the molecule is bound on the nanoparticle surface and so bound nanoparticles are 
unlikely to dissociate. This leads to the conclusion that the products are more 
thermodynamically stable than the reactants. The formation of nanostructures is driven 
by antigen adsorption on an antibody functionalized nanoparticle surface and the 
association of antigen-bearing nanostructures. Previous work by Dr. Sassiat estimated 
the rate of encounter of 20 nm nanoparticles and Re2(DMAA)4(NCS)2  linker molecules 
to be of the order of seconds.  Considering the 40 nm nanoparticles employed in this 
work we can deduce that antigen binding on the nanoparticles is complete within a short 
time interval (seconds) and the nanoparticle coverage with antigen molecules remains 
the dominant factor in controlling the nanostructure formation process. The max 
number of antigen molecules that can bind on the nanoparticle surface was determined 
to be 8 which correlates with the number of antigen molecules determined 
experimentally which resulted in slow/restricted nanostructure formation.    
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Figure 2.16:  Experimental data fitting employing the rate-equation model for distributions of 
nanoparticle assemblies counted at various time intervals taken from a solution of CRP antibody-
functionalised nanoparticle solution to which 9 µL 0.1 mg/mL CRP antigen solution was added. 
 
 
Parameter Output Parameter Output 
R2 0.913 Ea NP ml  120 meV 
ha (µm3s-1) 5.4E-5 Ed NP ml  450 meV 
hd (s-1) 1.5E-5 ∆H NP ml  -330 meV 
ka (µm3s-1) 4.9E-3 Ea cl cl  60 meV 
kd (s-1) 2.5E-3 Ed cl cl  400 meV 
mlmax 8 ∆H cl cl  -340 meV 
Table 2.2: Summary of the rate-equation output parameters at 60 minutes after commencement of the 
nanostructure formation process, corresponding to Figure 2.16. 
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2.4 Conclusions 
Nanoparticle self-assembly was demonstrated as an attractive technique to facilitate 
point-of-care detection of C-reactive protein (CRP). A CRP antigen concentration of 
0.06 µg/mL was detected evidenced as a distinct solution colour change from red to 
blue within 5 minutes. The strong light scattering of the gold nanoparticles facilitated 
this visual detection void of complex chemical processes and elaborate equipment, 
facilitating rapid inexpensive POC detection while concurrently maintaining the 
specificity, stability and sensitivity of the assay.  
Employing just gold nanoparticles functionalized with CRP antibodies and CRP antigen 
as linker molecules, control of the rate of nanoparticle recognition-induced self-
assembly was achieved between that of rapid formation of large nanostructures with 
associated solution colour change from red to blue within 5 minutes, and slow 
formation of small nanostructures over hours with no discernable solution color change.  
The key factor causative of that controlled self-assembly being the linker molecule-
nanoparticle ratio and can be controlled to enable detection across a wide CRP 
concentration range.  
Such control of the rate of nanoparticle self-assembly was corroborated employing 
nanoparticles of different functionality demonstrating applicability to detection of other 
molecules of interest. The self-assembly of 60 nm citrate-stabilized gold nanoparticle 
solution and Re2(DMAA)4(NCS)2  linker molecules also resulted in a distinct solution 
colour change from red to blue within 5 minutes while elevated Re2(DMAA)4(NCS)2     
linker molecule concentrations resulted in slow/restricted nanostructure formation. 
Such a sensitive, specific, stable, rapid detection mechanism provides for POC sensing 
at, for example, a GP surgery or hospital setting, using a hand-held spectrometer, 
facilitating provision of immediate and accurate test results. It also provides for 
detection at a range of near-patient settings, most particularly in resource-constrained 
settings, providing a simple, inexpensive visual detection means.  
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3.1 Introduction 
Employing just gold nanoparticles functionalised with C-reactive protein (CRP) 
antibodies and CRP antigen as linker molecules, control of the rate of solution-phase 
nanoparticle recognition-induced self-assembly was achieved resulting in visual 
detection of CRP within 5 minutes, demonstrating applicability to point-of-care (POC) 
sensing. Surface-based assays also show much promise in application to POC sensing. 
It was of interest to determine if surface-based assays void of complex chemical 
processes and elaborate equipment could compete with laboratory-based assays in terms 
of specificity, stability and sensitivity but also offer faster and inexpensive diagnosis. 
The binding of CRP antibody to silanised silicon-silicon oxide substrates with gold 
micron-scale electrodes implemented using the organosilane (3-
Aminopropyl)triethoxysilane  (APTES) and the subsequent binding of CRP antigen to 
this immobilised CRP antibody was explored. When a protein is immobilised on the 
surface of an electrode pair it introduces a capacitance component in the impedance 
response of the sensor. When the pair of electrodes is exposed to another protein that 
couples to the immobilised protein, a complex is formed, resulting in a corresponding 
decrease of the sensor capacitance.  
The binding of antigen to antibody however results in small and extremely localised 
conformational and charge related changes in the antibody structure which have proven 
difficult to measure with great sensitivity. Despite the limitations associated with 
surface-based assays, electrical characterisation of the binding event of CRP antigen to 
surface immobilised CRP antibody in ambient conditions facilitates characterisation of 
the reaction occurring at the biosensor surface in the presence of such limitations to 
determine if nanoparticle amplification would be required to facilitate rapid surface-
based POC detection of CRP.  
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3.2 Experimental 
3.2.1 Chemical modification of substrate surface through silanisation 
Classical 100 mm wafers of silicon, p-type (~ 1 – 30 mΩ.cm) were used. Wafers were 
oxidised in a furnace providing a smooth natural 300 nm of silicon oxide. Electrodes 
were fabricated using optical beam lithography, metal evaporation and lift-off 
employing a mask composed of 500 nm thick gold electrodes and gap sizes with critical 
dimensions down to 1 µm. Also, larger contact pads for ease of probing. Substrate 
preparation involved immersion in R1165 followed by a solvent clean and plasma 
ashing 50 W 1.5 Torr 10 minutes (March GCM-200, March Instruments Inc.). The role 
of key parameters such as silane type, solvent used, reaction time and concentration has 
been researched extensively previously as described in literature. 1,2,3,4 In this research, 
liquid phase silanisation was performed under ambient conditions using APTES - (3-
Aminopropyl)triethoxysilane 99% (Sigma Aldrich). APTES chemically modifies the 
surface without forming a layer of appreciable thickness. For practical purposes, it is 
readily available for purchase and relatively inexpensive. Silanisation conditions of 3% 
APTES in methanol: ultrapure deionised water 19:1 and a reaction time of 30 minutes 
were used. After immersion of the substrates in silane solution for 30 minutes, they 
were rinsed in methanol and then ultrapure deionised water and dried in a stream of 
nitrogen. The substrates were then cured in an oven at 120°C for 15 minutes. Following 
this they were immersed in 20 nm citrate-capped nanoparticle solution, optical density 1 
for 3 hours to determine the efficiency of the pre-treatment and silanisation processes.  
 
3.2.2 Surface immobilisation of CRP antibody and antibody-antigen binding   
C-reactive protein antibody (CRP) was covalently bound to the silanised substrates. A 
temperature of 4°C was used and a concentration of 100 µg/mL prepared by dilution of 
the as supplied CRP antibody with phosphate buffered saline (PBS) solution. A 50 µL 
aliquot of this CRP antibody solution was placed on each substrate and kept in humid 
conditions at 4°C overnight (16 hours). Substrates were then rinsed with 10 mM PBS 
buffer + BSA before binding of CRP antigen. Again this process was repeated a number 
of times to ensure reproducibility (determining binding process using goat anti-mouse 
(GAM) conjugate to mark the presence of the CRP antibody). Control experiments were 
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performed to ensure that antiCRP NPs did not directly bind to the CRP antibody 
functionalised surface in the absence of CRP antigen. Binding of CRP antigen to CRP 
antibody was performed at antigen concentrations of 10 µg/mL and 20 µg/mL.  
 
3.2.3 Electrical characterisation of CRP antibody-antigen binding   
Substrates were mounted in a manual probe station (Wentworth Laboratories PML 
8000) using low-leakage, manual, linear motion probe arms (Wentworth Laboratories 
PVX500) and shielded by a Faraday cage. Substrates were initially optically examined 
to ensure structural integrity of the devices. Measurements were performed using an 
Agilent E4980A LCR meter, incorporating VEE software interfaced to a PC. The 
influences of unwanted stray capacitance, e.g. cables are eliminated by calibration by 
performing an open and short measurement. Initially large voltage bias and frequency 
conditions were explored. It was found that instabilities, e.g. hysteresis were minimal at 
voltage biases ~ 20 mV. 100.025 kHz was employed as the frequency to characterise the 
binding event. Devices were characterised in ambient conditions. The source drain bias 
was swept in the sequence -20mV 0V +20mV 0V -20mV for all measurements to 
quantify the influence of hysteresis, obtaining therefore two different traces for a given 
bias polarity. Initial survey measurements of devices were performed using 20 data 
points per sweep with voltage step sizes of 2 mV. Later 80 data points were used with 
voltage step sizes of 0.5 mV.  
 
3.2.4 ANSYS simulations 
Simulations pertaining to the silicon-silicon oxide substrates and gold micron-scale 
device structures were performed by Mr Liam Floyd, Compound Semiconductors 
Group, at Tyndall National Institute using ANSYS Q3D Extractor. The device structure 
is laid out for Ground-Signal S-parameter measurements so in the simulations these 
were simulated and then the resistance, capacitance, line inductance and leakage 
conductance determined. A 3D model of the device structure was employed in the 
simulations. Capacitance values were simulated whereby a quasi-static electromagnetic 
field analysis using Finite Element Method (FEM) was employed. FEM involves 
splitting the entire volume of the structure under analysis into a 3D mesh involving 
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different shapes, for example, tetrahedrals, polygons and rectangular blocks. Initially a 
course mesh attempts a solution, whereby the regions where the quantities of electric 
and magnetic fields are changing most rapidly are examined, following which these 
regions are meshed more finely to reach the solution. This precedes matrix calculations 
to estimate the electric and magnetic fields. The electric and magnetic fields are 
considered separately but finally coalesced to reach a combined solution.  
 
3.2.5 Dielectrophoresis 
Prior to dielectrophoresis electrodes were solvent cleaned. Any residue on the electrodes 
impedes the dielectrophoretic trapping process.  All chips were ashed in O2 plasma 
(March Plasmod, 0.5 Torr, 20 W, 3 min).  A waveform generator Agilent AG33220A 
was used to carry out dielectrophoresis. The samples were mounted in a manual 
Wentworth PML8000 probe station. A drop (10 μL) of nanoparticle solution, diluted 
1:10 with ultrapure deionised water was placed on the substrate. AntiCRP nanoparticle 
solution diluted with ultrapure deionised water and also PBS solution was also 
employed. In most cases where the probes were lowered prior to adding a drop of the 
nanoparticle solution, damage to the electrodes was obvious even by optical inspection.  
Therefore, the probes were lowered to the substrate after the drop of nanoparticle 
solution had been added. Voltage and frequency parameters as well as trapping time 
were optimised.  
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3.3 Results and Discussion 
3.3.1 Electrical characterisation of CRP antibody-antigen binding   
Measured capacitance was employed as it resulted in greatest repeatability and 
reproducibility. Initially many measurements were performed on each device to 
determine stability and repeatability, with ΔCmax between repeat measurements = 1.1E-
15 and between voltage steps = 3E-16. Following this, one measurement was performed 
per device, see figure 3.1. 
 
Figure 3.1: Five measurements in succession were carried out on devices. ∆Cmax between repeat 
measurements = 1.1E-15 and between voltage steps = 3E-16. 
  
Measured capacitance of devices on silicon-silicon oxide substrates prior to surface 
functionalisation revealed a clear differentiation between capacitances of row 1 and row 
4 devices and row 2 and row 3 devices, likely due to electric field effects of 
neighbouring devices, i.e. row 1 and row 4 devices have devices adjacent to them on 
only one side while row 2 and row 3 devices have devices adjacent to them on both 
sides, see figure 3.2. This trend was accounted for in successive measurements.  
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(a) 
 
(b) 
 
(c) 
 
Figure 3.2: Measured capacitances (a) show a clear differentiation between those of row 1 and 4 devices 
and row 2 and 3 devices represented schematically in (b) prior to surface functionalisation, represented 
schematically in (c).  
 
 
Measurements were performed dry on each 2 µm device (devices 12 – 24) and each 5 
µm device (devices 37 – 48) for each process step commencing with the APTES 
functionalisation and antibody immobilisation steps, see figure 3.3.  
 
(a) 
 
(b) 
 
  
Figure 3.3: Measured capacitances of substrates (a) functionalised with APTES and (b) following C-
reactive protein (CRP) antibody immobilisation.  
 
____________________________________________________________________Chapter 3 
 
71 
 
A control measurement was performed whereby, substrates with CRP antibody 
immobilised were immersed in phosphate buffered saline (PBS) solution for 2 hours, to 
ensure integrity of the immobilised antibody layer post immersion in PBS solution, as 
employed in antigen binding steps. No appreciable change in capacitance was observed, 
see figure 3.4. 
 
(a) 
 
(b) 
 
(c) 
 
Figure 3.4: (a) Measured capacitances of substrates with C-Reactive protein (CRP) antibody immobilised 
and substrates with CRP antibody immobilised followed by immersion in phosphate buffered saline 
(PBS) solution for 2 hours, represented schematically in (c), demonstrates integrity of the immobilised 
antibody layer post immersion in PBS solution with (b) no appreciable change in capacitances.  
 
The electrical characterisation which is of importance in detection of CRP is the 
characterisation of the binding of CRP antigen to CRP antibody. The measurement 
performed is a differential one. If there was no response to the control addition and there 
was a response to addition of CRP antigen then it was considered that a positive 
response specific to antigen binding antibody was seen. When antigen bound antibody, 
a resulting decrease in capacitance was observed. The limitations associated with the 
small signal intrinsic of biomolecular binding of antigen to antibody were evident. The 
magnitude of change in capacitance depended both on the concentration of the CRP 
antigen and also the length of time the devices were exposed to CRP antigen solution, 
see figure 3.5 whereby substrates were exposed to 10 µg/mL CRP antigen for 2 hours, 
figure 3.6 substrates exposed to 20 µg/mL CRP antigen for 10 minutes and figure 3.7 
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substrates exposed to 20 µg/mL CRP antigen for 2 hours, demonstrating detection of 
CRP antigen in a clinically relevant range.  
 
(a) 
 
(b) 
 
(c) 
 
Figure 3.5: (a) Measured capacitances of substrates post C-reactive protein (CRP) antibody 
immobilisation and binding of CRP antigen (10 µg/mL 2 hours), (b) ΔC and (c) schematic representation.   
 
(a) 
 
(b) 
 
(c) 
 
 
Figure 3.6: (a) Measured capacitances of substrates post C-reactive protein (CRP) antibody 
immobilisation and binding of CRP antigen (20 µg/mL 10 mins), (b) ΔC and (c) schematic representation.   
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(a) 
 
(b) 
 
(c)  
 
Figure 3.7: (a) Measured capacitances of substrates post C-reactive protein (CRP) antibody 
immobilisation and binding of CRP antigen (20 µg/mL 2 hours), (b) ΔC and (c) schematic representation.   
 
3.3.2 ANSYS simulations 
Simulations employing a 3D model of the device structure, see figure 3.8 (a), enabled 
prediction of the performance and improvement of substrates aimed towards surface-
based point-of-care detection. Capacitance was simulated whereby a quasi-static 
electromagnetic field analysis using finite element method was employed. Initial 
simulations were performed taking the silicon to be lossless. The simulated values of 
line resistance, conductivity of the gold and line inductance agreed with calculated and 
previously reported values 5 with simulated leakage conductance = 0 as expected for 
lossless silicon. Simulations were then performed of the entire device structure setting 
the silicon resistivity at 3 S/m, see figure 3.8 (b) which is in agreement with measured 
capacitance values, see figure 3.2. 
 
These simulations demonstrate that leakage through the substrate dominates the 
electrical response when measurements are taken at 100.025 kHz. When the silicon 
resistivity was set at 100 times better than the present upper resistivity of 3 S/m, i.e. 
0.03 S/m, combined with measurement in the > 10 GHz regime, such losses are 
overcome, see figure 3.8 (c). Alternative means to overcome such losses include use of 
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quartz or ceramic substrates. However, simulations also reveal that water, even in the 
form of a layer of moisture on the device surface, contributes greatly to the capacitance 
response, see figure 3.8 (d) and even on elimination of losses through the substrate this 
contribution has to be considered. This guides further development of the process 
potentially enabling application to electrical surface-based point-of-care detection of 
analytes of interest. 
  
(a) 
 
(b) 
 
(c) 
 
(d) 
 
Figure 3.8: Simulations as performed in ANSYS employing a 3-D model of the device structure (a)  
(with exaggerated dimensions) and quasi-static electromagnetic field analysis using finite element method 
to estimate capacitance associated with lossless silicon-silicon oxide substrates and silicon with resistivity 
of (b) 3 S/m and (c) 100 times better than the present upper resistivity of 3 S/m (0.03 S/m). Also, (d) 
setting the silicon resistivity as lossless with the device structure covered in water.    
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3.3.3 Dielectrophoresis 
While electrical characterisation facilitated characterisation of the reaction occurring at 
the biosensor surface in the presence of limitations such as small charge related 
changes, it was deemed advantageous to employ nanoparticle amplification to facilitate 
rapid point-of-care surface-based detection of CRP. Dielectrophoresis was explored as a 
means for the directed assembly of nanoparticles and nanostructures between gold 
micron-scale electrodes using AC electric fields with frequencies in the MHz range. 6,7,8 
Voltage and frequency parameters as well as trapping time were optimised. The data 
shows a clear influence of the peak-peak voltage on the quantity of nanoparticles 
trapped. The SEM images show increasing numbers of nanoparticles trapped as Vp-p 
was increased, see figure 3.9.  
 
(a) 
 
(b) 
 
Figure 3.9: Scanning electron microscopy (SEM) images of microelectrodes (500 nm gaps) used to 
investigate the voltage required to overcome the electrostatic potential at the electrode-solution interface 
for d = 40 nm citrate-capped gold nanoparticles, (a) fdep = 1 MHz, tdep = 300 s, V = 8 V, (b) fdep = 1 
MHz, tdep = 300 s, V = 10 V. 
 
Hence f=1 MHz and peak-to-peak amplitude (Vp-p) in the range of 8 V ≤ Vp-p ≤ 10 V 
being applied for 5 minutes resulted in trapping of particles in > 90% of devices, the 
process being repeated across 3 sets of 4 microgaps each on the same chip. On 
completion of dielectrophoresis substrates were briefly rinsed in ultrapure deionised 
water and blown dry in a gentle stream of nitrogen. Figure 3.10 illustrates positive 
dielectrophoresis of citrate-capped gold nanoparticles of core diameter 80 nm resulting 
in the directed assembly of the nanoparticles within the electrode gaps. Further, little or 
no trapping was observed in control gaps (no voltage applied). Scanning electron 
microscopy (SEM) imaging was used to determine the degree to which nanoparticles 
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were directly assembled between the electrodes.  Imaging was the final step in each 
experiment. SEM data obtained at lower magnification for each device confirmed low 
incidence of nanoparticles outside the region in which dielectrophoresis was carried out, 
ruling out the possibility of random assembly. 
 
(a) 
 
(b) 
 
Figure 3.10: Scanning electron microscopy (SEM) images of microelectrodes (500 nm gaps) used for 
initial dielectrophoretic trapping of citrate capped gold nanoparticles with core diameters of d = 80 nm at 
fdep = 1 MHz, tdep = 300 s, V = 10 V. 
 
However repeating this procedure using antiCRP NPs in ultrapure deionised water 
resulted in electrothermal effects having a significant influence on the dielectrophoretic 
process, see figure 3.11 (a). Furthermore, DEP trapping of antiCRP NPs and antiCRP 
nanostructures in 100 mM PBS buffer, required to mimic physiological conditions, 
resulted not only in negative dielectrophoresis as a result of the conductivity of the 
solution and overall negative real part of Clausius-Mossotti factor Re[Κ(ω)] but also 
resulting damage to the electrodes, see figure 3.11 (b), even at low voltages and a range 
of frequencies, ruling out the potential of this proposed technique as a means to 
electrically characterise nanoparticle assemblies formed via CRP antibody-antigen 
recognition induced self-assembly. 
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(a) 
 
(b) 
 
Figure 3.11: SEM images of microelectrodes (500 nm gap) displaying (a) partial trapping of CRP 
antibody functionalised gold nanoparticles dissolved in water (fdep = 1 MHz, tdep = 300s, V = 10 V), (b) 
damage as a result of trapping CRP antibody functionalised gold nanoparticles in 100 mM PBS buffer 
(fdep = 1 MHz, tdep = 300 s, V = 10 V). 
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3.4 Conclusions 
The binding of CRP antibody to silanised silicon-silicon oxide substrates with gold 
micron-scale electrodes implemented using the organosilane (3-
Aminopropyl)triethoxysilane  (APTES) and the subsequent binding of CRP antigen to 
this immobilised CRP antibody was explored. The formation of the antibody-antigen 
complex resulted in a corresponding decrease of the sensor capacitance employing a 
CRP antigen concentration of 20 µg/mL for 2 hours.  
It is concluded the molecular functionalization is successful for these devices and the 
net decrease in capacitance is a signature of successful binding of CRP antigen to CRP 
antibody immobilised on the substrate surface. Measurement protocols were reported 
and CRP was detected in a clinically relevant range mimicking point-of-care conditions. 
The binding of CRP antigen to CRP antibody however resulted in small charge related 
changes which were difficult to measure with great sensitivity.  
The means to overcome limitations presented in using silicon-silicon oxide substrates in 
electrical detection of CRP was identified employing simulations performed in ANSYS. 
There lies potential in utilising this detection mechanism to establish a differential 
immunosensor where difference in response between a single antibody layer and an 
antibody layer to which antigen has bound can be detected.  It presents a platform from 
which to work on to develop the electrical detection process further, using optimised 
electrode design and substrates and potentially real time measurements in buffer ideally 
in a flow through cell involving the addition of the sample containing CRP antigen 
yielding the result.  
While the reaction occurring at the biosensor surface was electrically characterised in 
the presence of such limitations it was deemed advantageous to employ nanoparticle 
amplification to facilitate rapid point-of-care surface-based detection of CRP. In that 
regard dielectrophoresis was explored as a means for the directed assembly of 
nanoparticles and nanostructures between gold micron-scale electrodes. However it was 
demonstrated that the PBS solution employed to mimic physiological conditions did not 
accommodate positive dielectrophoresis.  It was therefore deemed advantageous to 
consider nanoparticle amplification in surface-based assays without electrical detection.  
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4.1 Introduction 
The binding of CRP antibody to silanised silicon-silicon oxide substrates with gold 
micron-scale electrodes was implemented using the organosilane (3-
Aminopropyl)triethoxysilane  (APTES) and CRP antigen was subsequent bound to this 
immobilised CRP antibody. The formation of the antibody-antigen complex resulted in 
a corresponding decrease of the sensor capacitance representing successful molecular 
functionalization. The binding of antigen to antibody however resulted in small charge 
related changes which were difficult to measure with great sensitivity.  
While electrical characterisation facilitated characterisation of the reaction occurring at 
the biosensor surface in the presence of such limitations it was deemed advantageous to 
employ nanoparticle amplification to facilitate rapid surface-based detection of CRP, 
void of elaborate equipment, applicable to POC detection of CRP. A tracer is often used 
to generate a signal, for example, optical, electrochemical, or radioisotopic decay, which 
enables quantitation of the amount of bound antigen. The number of target molecules 
can then be converted to a specific measure. Traditionally radioisotopes and 
fluorophores have been used but challenges relating to poor stability, low sensitivity and 
difficult sample processing exist. Nanoparticles offer a simple, sensitive alternative. 
The binding of CRP antigen to surface immobilised CRP antibody was marked by gold 
nanoparticles functionalised with CRP antibodies (antiCRP NPs) and the numbers of 
bound nanoparticles analysed numerically employing imageJ software. Such 
nanoparticle tracers enable estimation of the amount of bound antigen and visual 
detection of CRP 1,2,3 demonstrating potential of nanoparticle tracers to facilitate rapid 
surface-based point-of-care detection of CRP.  
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4.2 Experimental 
4.2.1 Binding of CRP antigen to surface immobilised CRP capture antibody  
Substrate surface silanisation and immobilisation of CRP antibody was performed as 
described in chapter 3 of this thesis. Binding of CRP antigen to CRP antibody was 
performed at antigen concentrations of 5 µg/mL and 20 µg/mL. CRP antigen binding 
was marked by the presence of antiCRP NPs. Factors which may affect the binding of 
the nanoparticles to the CRP antigen were investigated, such as optical density and 
length of time of immersion to ensure that optimum binding was achieved. Control 
experiments were performed by replacing antiCRP NPs with BSA-capped NPs. 
4.2.2 ImageJ analysis  
In the imageJ programme the required scanning electron microscopy (SEM) image is 
selected. The size scale is set according to the scale as per SEM image. This relates the 
number of pixels in the image and the size of the features, which are in this case the 
nanoparticles (NP) and nanostructures (NS). The image is then cropped to include just 
the part of the SEM image excluding the SEM imaging details bar. The programme 
identifies and outlines the edges of NP/NS in the image. The image threshold can be 
adjusted to ensure that all NP/NS are selected and clearly defined by the edge outline 
line. The “smooth” function is then selected to remove background interference. The 
image is made binary and “dilate” function selected, which ensures that NP of a 
nanostructure (NS) assembly are combined together so as that the programme 
recognises them as a nanoparticle assembly as not as individual nanoparticles. The 
diameter of one NP is then measured using the “Analyse, measure” function. The entire 
image is selected, selecting all nanoparticles and nanostructures. The required 
measurements are set using the “Analyse, set measurements” function and all NP/NS in 
the image counted using the “Analyse, analyse particles” function. This outputs a list of 
results which includes the number of NS identified and the corresponding mean area. 
The areas corresponding to monomers, dimers etc. were recorded and from this, area 
ranges associated with each of the various NS sizes from monomers to assemblies 
containing 10 nanoparticles was established. This provided the number of each sized NS 
per SEM image. 
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4.3 Results and Discussion 
4.3.1 Chemical modification of substrate surface through silanisation 
It was crucial that the substrates, which chemical reactions are performed on to modify 
the surface to allow covalent coupling of the biological constituent, in this case via 
substrate silanisation, were sufficiently clean to eliminate any contaminants that would 
interfere with the functioning of the bio-layer and modified so as to generate the 
maximum number of available reactive hydroxyl groups for surface functionalisation. 
Control experiments were performed to ensure that neither citrate-capped gold NPs or 
antiCRP gold NPs bound non-specifically to the cleaned substrate surface. To 
investigate the degree of non-specific binding of antiCRP NPs to the silicon-silicon 
oxide substrate surface, substrates were immersed in antiCRP NP solution @ optical 
density (OD2) for 3 hours which equates to approximately 1.8E11 NPs supplied. This 
resulted in binding of on average 2 NPs per 6.5 x 4.5 µm area, 4E6 NPs binding per 
substrate, see figure 4.1 (a). Similarly, substrates were immersed in 20 nm citrate-
capped gold NP solution @ OD1 for 3 hours, equating to approximately 7E11 NPs 
supplied. This resulted in on average 0 NPs binding per 6.5 x 4.5 µm area, 0 NPs 
binding per substrate, see figure 4.1 (b). 
 
(a) 
 
(b) 
 
Figure 4.1: Scanning electron microscopy (SEM) images depicting the surface nanoparticle density on 
immersion of substrates post cleaning in (a) antiCRP NP solution at OD2 RT for 12 hours (≈ 2 particles 
binding per 6.5 µm x 4.5 µm area), (b) citrate-capped gold NP solution at OD1 RT for 12 hours (≈ 0 
particles binding per 6.5 µm x 4.5 µm area). 
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Following substrate preparation the substrate surface was chemically modified through 
silanisation. The chemical and physical nature of the silane layer is of utmost 
importance as it directly influences the morphology and surface density of subsequently 
cross-linked molecules. The method used to determine the density and homogeneity of 
the silanisation layer formed involves immersion of the silanised substrates in a solution 
of 20 nm diameter citrate capped gold NPs. The negatively charged citrate capped gold 
NPs can bind to the positively charged amine group of the APTES molecules on the 
substrate surface.  
APTES-functionalised substrates were immersed in citrate-capped NP-solution @ OD1 
for 3 hours, equating to approximately 7E11 NPs supplied. This resulted in, on average 
900 NPs binding per 6.5 x 4.5 µm area, 2E9 NPs binding per substrate, implying that 
there are at least 2E9 active APTES binding sites. The NP density obtained most likely 
represents the lower limit of available APTES binding sites, depicting a situation 
resulting from the electrostatic repulsion of citrate NPs rather than a limited population 
of APTES binding sites, see figure 4.2 (a). The number of bound NPs does not increase 
with longer immersion times despite possible unoccupied APTES binding sites on the 
surface, as the repulsive electrostatic forces exercised by neighbouring NPs prevent 
binding of further NPs on the substrate surface.  
It is also of interest to determine the degree of non-specific binding of antiCRP NPs to 
the APTES-functionalised surface. In this case APTES-functionalised substrates were 
immersed in 40 nm antiCRP gold NP solution @ OD2 for 3 hours, equating to 
approximately 1.8E11 NPs supplied. This resulted in, on average 3 NPs binding per 6.5 
x 4.5 µm area, 6E6 NPs binding per substrate, see figure 4.2 (b).  
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(a) 
 
(b) 
 
Figure 4.2: Scanning electron microscopy (SEM) images depicting the surface nanoparticle density on 
immersion of APTES functionalised substrates in (a) citrate-capped gold NP solution at OD1 RT for 3 
hours  (≈  900 NPs binding per 6.5 µm x 4.5 µm area), (b) antiCRP gold NP solution at OD2 RT for 3 
hours (≈ 3 NPs binding per 6.5 µm x 4.5 µm area).  
 
4.3.2 Covalent attachment of CRP antibody  
To determine the degree of binding of antiCRP NPs to the CRP antibody-functionalised 
substrate surface, antibody functionalised substrates were immersed in 40 nm gold 
antiCRP NP solution @ OD2 for 3 hours. This resulted in binding of, on average 8 NPs 
per 6.5 x 4.5 µm area, 1.7E7 NPs per substrate, equating to approximately binding of 1 
in 100 resulting from non-specific binding, see figure 4.3. 
 
Figure 4.3: Scanning electron microscopy (SEM) image depicting the surface NP density on immersion 
of antibody functionalised substrates in 40 nm antiCRP gold NP solution at OD2 3 hours ≈ 8 NPs per 6.5 
x 4.5 µm area (≈ 1.7E7 NPs binding per chip ≈ binding of 1 in 100 sites due to non-specific binding). 
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4.3.3 Binding of CRP antigen to surface immobilised CRP capture antibody  
The detection of CRP antigen is determined by binding of the antigen to surface 
immobilised CRP antibody. The presence of CRP antigen is marked by antiCRP NPs. 
Substrates with antibody immobilised and antigen bound were immersed in 40 nm 
antiCRP gold NP solution @ OD2 for 1 hour. With approximately 2E9 APTES binding 
sites and approximately 5.4E12 antigens supplied, equates to approximately 2700 
antigens per APTES site. With ≈ 1.8E11 NPs supplied and ≈ 9.8E8 NPs binding on the 
substrate surface, this results in binding of 1 in 2 APTES sites with antiCRP NPs. 
Figure 4.4 (a) displays the surface NP density of the antiCRP NPs on the substrate 
surface, marking the presence of the CRP antigen (20 µg/ml 2 hours). Each NP marks 
the presence of a CRP antigen molecule which has bound to a CRP antibody. Decreased 
binding activity results due to the orientation of the surface bound molecules, alteration 
of conformation of the receptor molecule on interaction with the surface, steric factor 
and altered kinetics.  
As a control experiment, BSA passivated NPs were used in place of antiCRP NPs. 
Substrates with CRP antibody immobilised to which CRP antigen (20 µg/mL) was 
bound were immersed in 40 nm BSA passivated NP solution @ OD2 for 3 hours, 
equating to approximately 1.8E11 NPs supplied, with on average, 0 NPs binding per 
substrate, see figure 4.4 (b). This is not surprising as an antibody will combine 
specifically with the corresponding antigen. Even a small change, for example, the 
substitution of one amino acid for another, moving a chemical group from one carbon to 
another, or using the mirror image of a chemical group may change the antibody-
antigen fit from very good to weak or non-interacting.4 It is expected that a small 
number of NPs could bind as proteins always adsorb to some extent onto a solid 
surface. This adsorption is energetically favoured because of the decrease in interfacial 
tension and resultant decrease in the Gibbs energy of the system.  
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(a) 
 
(b) 
 
Figure 4.4 Scanning electron microscopy (SEM) images depicting the surface NP density of (a) the 
antiCRP NPs @ OD2 for 1 hour on the substrate surface marking the presence of the CRP antigen (20 
µg/mL 2 hours), (b) 40 nm BSA passivated NP solution @ OD2 for 3 hours (≈ 1.8E11 NPs supplied ≈ 0 
NPs binding per chip).  
 
5 µg/mL CRP antigen for 2 hours resulted in sparse and inhomogeneous coverage with 
on average 675 antigens available per APTES binding site resulting in binding to ≈ 1 in 
20 available APTES sites, see figure 4.5.  
 
 
Figure 4.5: Scanning electron microscopy (SEM) image depicting the surface NP density of antiCRP 
NPs marking the presence of the CRP antigen (5 µg/mL 2 hours).  
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4.3.4 Image J analysis  
ImageJ analysis enabled precise quantification of numbers of nanoparticles bound to the 
substrate surface. This enabled accurate relation of tracer signal – in this case 
nanoparticles, to concentration of CRP antigen present in the sample. Substrates 
(APTES functionalised; 100 µg/mL CRP antibody 4°C 16 hours) were exposed to 20 
µg/mL CRP antigen RT for various times (a) 10 min (b) 60 min and (c) 120 min 
followed by immersion in antiCRP NP solution for 60 minutes. The number of 
individual NPs as well as the number of nanostructures (NS) of various sizes up to 10 
NP were counted using Image J for each of 5 SEM images analysed per time point, see 
figure 4.6. The total of each sized NS entity across the 5 images was then established, 
followed by the average number of each. The ratio of individual NP to NS was then 
calculated for each of the 4 time points. This lead to estimation of the degree of NP 
binding to chemisorbed CRP antigen as opposed to binding of antiCRP NPs to 
physiosorbed antigen.  
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(a) 
  
(b) 
  
(c) 
  
Figure 4.6: Scanning electron microscopy images depicting surface NP density and corresponding 
ImageJ output programme images outlining the various nanoparticles (NP)/nanostructures (NS) present at 
each time interval for 20 µg/mL CRP antigen RT for various lengths of time (a) 10 min (b) 60 min and (c) 
120 min and immersion in antiCRP nanoparticle solution for 60 min.  
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Table 4.1 shows the total numbers of individual nanoparticles (NP) and nanostructures 
(NS) recorded for the 5 images for each time interval that the substrates were immersed 
in antiCRP nanoparticle solution for 60 minutes. The ratio of NP to NS is also shown in 
table 4.1. As the ratio of NS to individual NP decreases over time, it is suggestive that 
some length of time is required to facilitate formation of larger nanostructures. From 
this table of values the histogram in Figure 4.7 was plotted. 
 
 Antigen (min) NP (min) Total Monomers Ratio monomers :Nanostructures (NS) 
(a) 10 60 86 1 : 0.94 
(b) 60 60 97 1 : 0.76 
(c) 120 60 110 1 : 0.58 
(d) 120 10 82 1 : 0.29 
Table 4.1: (a – c) Average numbers of nanoparticles (NP) and nanostructures (NS) recorded for the 5 
scanning electron microscopy (SEM) images for each time point for which substrates (APTES 
functionalised; 100 µg/mL CRP antibody 4°C 16 hours) were exposed to (a – c) 20 µg/mL CRP antigen 
RT, followed by immersion in antiCRP nanoparticle solution for 60 min, including the ratio of individual 
NP to NS, (d) 20 µg/mL CRP antigen RT 2 hours followed by immersion in antiCRP nanoparticle 
solution for 10 min, including the ratio of individual NP to NS. 
 
 
Figure 4.7: Histogram displaying the ratio of individual nanoparticles (NP) to nanostructures (NS) 
recorded for the 5 scanning electron microscopy (SEM) images for each time point for which substrates 
were exposed to 20 µg/mL CRP antigen RT, followed by immersion in antiCRP NP solution for 60 min. 
Also, the ratio of individual nanoparticles (NP) to nanostructures (NS) for substrates exposed to 20 
µg/mL CRP antigen RT 2 hours followed by immersion in antiCRP nanoparticle solution for 10 minutes. 
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Further analysis of the data in the form of histogram plots of the % nanostructures 
containing numbers of nanoparticles from 1 to 10 when substrates were exposed to 
20 µg/mL CRP antigen, followed by immersion in antiCRP nanoparticle solution 
for 60 minutes highlights the conversion of smaller nanostructures into larger 
assemblies over time, see figure 4.8. Unlike solution phase formation of 
nanostructures, however, where gentle mixing can facilitate more rapid formation 
of nanostructures this surface-based nanostructure formation relies on diffusion 
alone. Histogram plots of the % nanostructures containing numbers of 
nanoparticles from 1 to 3 (no nanostructures > those containing 3 NP were 
formed) when substrates were exposed to 5 µg/mL CRP antigen, followed by 
immersion in antiCRP nanoparticle solution for 60 minutes demonstrates the 
potential of visual detection of CRP antigen, differentiating between a CRP 
antigen concentration of 5 µg/mL (baseline level cut-off point) and elevated levels 
of 20 µg/mL, see figure 4.9. 
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(a) 
 
(b) 
 
(c) 
 
(d) 
 
(e) 
 
(f) 
 
(g) 
 
(h) 
 
(i) 
 
(j) 
 
 
Figure 4.8: Histograms showing the distribution of nanostructures (NS) containing (a) one (b) two (c) 
three (d) four (e) five (f) six (g) seven (h) eight (i) nine (j) ten nanoparticles (NP) on substrate surfaces 
following immersion in 20 µg/mL CRP antigen solution for 10 minutes to 2 hours, followed by 
immersion in antiCRP NP solution for 60 minutes.  
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(a) 
 
(b) 
 
(c) 
 
 
Figure 4.9: Histograms showing the distribution of nanostructures (NS) containing (a) one (b) two and 
(c) three nanoparticles (NP) on substrate surfaces following immersion in 5 µg/mL CRP antigen solution 
for 10 minutes to 2 hours, followed by immersion in antiCRP NP solution for 60 minutes.  
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The use of antiCRP NPs as tracers to mark the presence of bound antigen to generate an 
optical signal provided a simple, sensitive, visual detection means free of elaborate 
equipment to detect for the presence of CRP antigen in a clinically relevant range. 
Immersion of substrates in 5 µg/mL CRP antigen for 2 hours followed by immersion in 
antiCRP nanoparticle solution for 60 minutes resulted in no visually detectable colour 
change of the substrate surface while immersion of substrates in 20 µg/mL CRP antigen 
for 2 hours followed by immersion in antiCRP nanoparticle solution for 60 minutes 
resulted in a distinct substrate surface colour change to pink, see figure 4.10.  
Additionally, the data in figures 4.8 and 4.9 is suggestive that CRP antigen immersion 
times of 10 minutes and immersion in antiCRP nanoparticle solution could also 
facilitate this visual detection of CRP, demonstrating potential of such nanoparticle 
amplification to facilitate rapid surface-based POC detection of CRP. It is envisaged 
that future work can facilitate this. 
 
 
 
Figure 4.10: Silicon-silicon oxide substrates (APTES functionalised; 100 µg/mL CRP antibody 4°C 16 
hours) which were exposed to (a) 5 µg/mL CRP antigen RT 2 hours followed by immersion in antiCRP 
nanoparticle solution for 60 min and (b) 20 µg/mL CRP antigen RT 2 hours followed by immersion in 
antiCRP nanoparticle solution for 60 minutes. 
 
 
 
 
 
 
____________________________________________________________________Chapter 4 
 
95 
 
4.4 Conclusions 
The binding of C-reactive Protein (CRP) antibody to silanised silicon oxide surfaces 
was implemented using the organosilane (3-Aminopropyl)triethoxysilane  (APTES) and 
the subsequent binding of CRP antigen to this immobilised CRP antibody was marked 
by the presence of antiCRP gold NPs. Scanning electron microscopy (SEM) imaging 
was used throughout as a means to establish the build-up of layers during the antibody 
immobilisation and antigen binding processes. ImageJ software was employed to 
numerically analyse the number of surface bound nanoparticles.  
 
Surface antiCRP NP coverage marking the presence of CRP antigen enabled estimation 
of the amount of bound antigen in the presence of limitations associated with surface-
based attachment mechanisms, such as poor receptor binding, random orientation of the 
receptor molecule, alteration of conformation of the receptor molecule on interaction 
with the surface, steric factor and altered kinetics. This facilitated estimation of 
sensitivity and speed of response, where it was demonstrated that nanoparticle 
amplification could facilitate rapid visual surface-based detection of CRP. 
 
In addition to solution-phase nanoparticle recognition-induced self-assembly, 
employing nanoparticle amplification in surface-based assays represents a detection 
means void of complex chemical processes and elaborate equipment which could 
compete with laboratory-based assays in terms of specificity, stability and sensitivity 
but also facilitate rapid surface-based point-of-care detection of CRP. The excellent 
binding specificity of gold nanoparticles offers a suitable platform for the selective 
binding and detection of biological targets. The advantages of integrating biomolecules 
with gold nanoparticles can generate materials that combine the properties of the 
nanoparticles with the molecular recognition properties of biomolecules. This provides 
for the analysis of cardiac markers such as CRP or diseases that can evolve rapidly in 
varying circumstances to be performed periodically at the point-of-care.  
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5.1 Conclusions 
Nanoparticle self-assembly was demonstrated as an attractive technique to facilitate 
point-of-care detection of C-reactive protein (CRP). A CRP antigen concentration of 
0.06 µg/mL was detected, evidenced as a distinct solution colour change from red to 
blue within 5 minutes. The strong light scattering of the gold nanoparticles facilitated 
this visual detection void of complex chemical processes and elaborate equipment, 
facilitating rapid inexpensive point-of-care detection while concurrently maintaining 
specificity, stability and sensitivity.  
Employing just gold nanoparticles functionalized with CRP antibodies and CRP antigen 
as linker molecules, control of the rate of nanoparticle recognition-induced self-
assembly was achieved between that of rapid formation of large nanostructures with 
associated solution colour change from red to blue within 5 minutes, and slow 
formation of small nanostructures over hours with no discernable solution color change.  
The key factor causative of that controlled self-assembly being the linker molecule-
nanoparticle ratio and can be controlled to enable detection across a wide range of CRP 
concentrations.   
Such control of the rate of nanoparticle self-assembly was corroborated employing 
nanoparticles of different functionality demonstrating applicability to detection of other 
molecules of interest. The self-assembly of d = 60 nm citrate-stabilized gold 
nanoparticle solution and Re2(DMAA)4(NCS)2  linker molecules also resulted in a 
distinct solution colour change from red to blue within 5 minutes while elevated 
Re2(DMAA)4(NCS)2     linker molecule concentrations resulted in slow/restricted 
nanostructure formation. 
Such a sensitive, specific, stable, rapid detection mechanism could provide for point-of-
care sensing at, for example, a GP surgery or hospital setting, using a hand-held 
spectrometer, facilitating provision of immediate and accurate test results. It also 
provides for detection at a range of near-patient settings, most particularly in resource-
constrained settings, providing a simple, inexpensive visual detection means. 
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Surface-based assays also show much promise in application to point-of-care detection. 
The binding of CRP antibody to silanised silicon-silicon oxide substrates with gold 
micron-scale electrodes was implemented using the organosilane (3-
Aminopropyl)triethoxysilane  (APTES) and the subsequent binding of CRP antigen to 
this immobilised CRP antibody was explored. The formation of the antibody-antigen 
complex resulted in a corresponding decrease of the sensor capacitance employing a 
CRP antigen concentration of 20 µg/mL (2 hours).  
It is concluded the molecular functionalization is successful for these devices and the 
net decrease in capacitance is a signature of successful binding of CRP antigen to CRP 
antibody immobilised on the substrate surface. Measurement protocols were reported 
and CRP was detected in a clinically relevant range mimicking point-of-care conditions. 
The binding of antigen to antibody however resulted in small charge related changes 
which were difficult to measure with great sensitivity.  
The means to overcome limitations presented in using silicon-silicon oxide substrates in 
electrical detection of CRP was identified employing simulations performed in ANSYS. 
There lies potential in utilising this detection mechanism to establish a differential 
immunosensor where difference in response between a single antibody layer and an 
antibody layer to which antigen has bound can be detected.  It presents a platform from 
which to work on to develop the electrical detection process further, using optimised 
electrode design, quartz substrates and potentially real time measurements in buffer 
ideally in a flow through cell involving the addition of the sample containing CRP 
antigen yielding the result.  
While electrical characterisation facilitated characterisation of the reaction occurring at 
the biosensor surface in the presence of such limitations it was deemed advantageous to 
employ nanoparticle amplification to facilitate rapid point-of-care surface-based 
detection of CRP, void of elaborate equipment. 
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The binding of CRP antibody to silanised silicon oxide substrates was implemented 
using the organosilane (3-Aminopropyl)triethoxysilane  (APTES) and the subsequent 
binding of CRP antigen to this immobilised CRP antibody was marked by the presence 
of antiCRP gold NPs. Scanning electron microscopy (SEM) imaging was used 
throughout as a means to establish the build-up of layers during the antibody 
immobilisation and antigen binding processes. ImageJ software was employed to 
numerically analyse the number of surface bound nanoparticles.  
 
Surface antiCRP NP coverage marking the presence of CRP antigen enabled estimation 
of the amount of bound antigen in the presence of limitations associated with surface-
based attachment detection mechanisms, such as poor receptor binding, random 
orientation of the receptor molecule, alteration of conformation of the receptor molecule 
on interaction with the surface, steric factor and altered kinetics. This facilitated 
estimation of sensitivity and speed of response, where it was demonstrated that 
nanoparticle amplification could facilitate rapid visual surface-based detection of 
between 5 µg/mL and 20 µg/mL CRP. 
 
In addition to solution-phase nanoparticle recognition-induced self-assembly, 
employing nanoparticle amplification in surface-based assays represents a detection 
means void of complex chemical processes and elaborate equipment which could 
compete with laboratory-based assays in terms of specificity, stability and sensitivity 
but also facilitate rapid surface-based point-of-care detection of CRP. The excellent 
binding specificity of gold nanoparticles offers a suitable platform for the selective 
binding and detection of biological targets. The advantages of integrating biomolecules 
with gold nanoparticles can generate materials that combine the properties of the 
nanoparticles with the molecular recognition properties of biomolecules. This provides 
for the rapid, inexpensive analysis of cardiac markers such as CRP to be performed 
periodically at the POC. 
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A.1 Abbreviations and Acronyms 
AC   Alternating current 
APR   Acute phase response 
APTES         (3-Aminopropyl)triethoxysilane 
BSA             Bovine serum albumin 
CHD            Coronary heart disease 
CPG            Capacitance-conductance in parallel 
CRP   C-reactive protein 
CVD   Cardiovascular disease 
DEP   Dielectrophoresis 
DLVO   Derjaguin  Landau Verwey Overbeek 
DNA   Deoxyribonucleic acid 
ELISA   Enzyme-linked immunosorbent assay 
FDA   Food and drug administration 
FWHM  Full width half maximum 
GAM   Goat anti-mouse 
GMM   Generalised Multiple Mie 
LAT   Latex agglutination test 
LCR   Inductance capacitance resistance 
LOD   Limit of detection 
NP   Nanoparticle 
NP   Nanostructure 
OD   Optical density 
PBS   Phosphate buffered saline 
POC   Point-of-care 
RNA   Ribonucleic acid 
RT   Room temperature 
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SAM   Self assembled monolayer 
SEM   Scanning electron microscopy 
SPR   Surface plasmon resonance 
UV   Ultra violet 
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